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Retrospective Study of Inspectors Competency in the Act of
Writing GMP Inspection Report
C.U. Uche1, Z. Ekeocha2, S. Byrn3, K. Clase4
ABSTRACT
The research was a retrospective study of twenty-five Good Manufacturing Practice (GMP) inspection reports
(from March 2017 through to December 2018) of a national medicine regulatory agency, drug Inspectorate, in
West Africa, designed to assess the inspectors’ expertise in the act of inspection report writing.
The investigation examined a paper-based tool of thirteen pre-registration Inspection reports and twelve GMP
reassessment reports written prior and following an intervention program by external GMP trainers to enhance
inspectors’ skill in pharmaceutical cGMP inspection.
The study made use of quantitative analysis to investigate each team’s expertise in the act of writing GMP
inspection report. Likewise, each report’s compliance with the requirements of three regulatory standards on GMP
inspection report writing was ascertained. Impact of intervention program on lead inspectors’ competence was
assessed. Lastly, gap in each team writing effectiveness, and lead inspectors’ abilities to deliver an effective report
were determined.
The results showed one of the inspection team (4.0%) wrote an excellent report. Two (8.0%) of the twenty-five
inspection teams penned good inspection reports. Eleven (44.0%) teams drafted needs improvement reports and
the remaining eleven teams (44.0%) prepared unacceptable reports.
The excellent report and the two good reports had report format that meet expectation. One (50.0%) of the good
reports showed the authors possess excellent knowledge of cGMP technical areas. The remain good report
(50.0%) revealed the writers’ knowledge.as good. The excellent report showed the authors displayed partial
mastery in the use of objective evidence while the two good reports disclosed theirs as having partial and evolving
abilities. One of the teams (50.0%) that wrote good reports displayed good use of third person narrative past
tense in report writing whereas the other team used the same tense and voice excellently.
Generally, a sort of marginal level of performance was prominent among the inspection teams. A gap, if not tackled,
will slow down regulatory process through increase report review, litigations that query report factual accuracy
(AIHO, 2017) and delay in issuance of marketing authorization.
In conclusion, trainings on quality attributes, such as technical content (Quality Management System (QMS) and
Site), the use of objective evidence, assignment of risk levels to GMP violations and citing of applicable laws,
regulation and guidelines that substantiate GMP observations, were recommended, to enhance knowledge
sharing and regulators’ performance in the act of writing inspection report.

KEYWORDS: Regulatory System, Good Manufacturing Practice, Pharmaceutical Inspectors, Inspectional
observation., Inspection report, compliance letter.
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Introduction
Knowledge and skill to write competently and in a way
which suits one’s goal and audience is a task which
many individuals never acquire in their first language,
even with the fact that significant part of the
educational process is devoted to developing of such
skills (May, 2015). Information sharing in a diversity of
written formats and for array of reasons is an act that
leads to analytical, critical, and logical thinking
(Fasset, 2019).The old saying that, “A job is not
complete until the paperwork is over,” is partially
correct (Fasset, 2019).Invariably, it should `be
understood that an effective report, is one which the
author need to articulate his or her point and relay the
information in such a manner that the reader will
understand exactly what he or she means (Your
dictionary, 2002).This means that reports have to be
presented as organised information based on sound
evidence that would unavoidably, lead to a logical
conclusion (Smyth, 2012). This educational skill is
highly valued by employers and should be assessed
from time to time, especially where what one writes
and how well he or she writes it, can affect people’s
lives (Smyth, 2012).
Writing competence” is defined as possessing the
required writing abilities to produce an orderly use of
words. With the support of written statement, it is
likely to communicate with individuals who are not
with us. The act of writing can be used to discern our
thoughts, and to visualize the realities of existence as
well as things that are yet to happen. Basic writing
competence was defined as the ability to make
effective use of basic writing functions such as
purposeful, in written art and handicraft. Through
purpose writing we share information for different
reasons in different situations. It could be through text,
words, spelling, sentences, composition and drawing
as well as other signs in written art and handicraft we
engage the intellectual, psychological, and physical
parts of skills to provide us with a well-written
document for a brilliant presentation (Kjell Lars Berge,
2009).
The aim of writing is often associated with the nature
of activity that goes on in a particular area. Therefore,
the way of writing in particular discipline reflect their
specific ideology, internal reason, and work ethics
(Kjell Lars Berge, 2009). FDA employees across the
globe write a range of documents, which include but
are not limited to letters and web content for a variety
of audiences, guidance documents, regulations,

compliance directives, consumer safety notices and
updates, recall notices, warning letters, press
releases, policies and procedures and GMP reports in
some climes(FDA, 2019).The high volume and wide
range of documents these employees handle, made it
essential that the competence of the regulators
involved in this task be assessed periodically, to
assure adherence to good documentation procedures
and good report writing practice. This would not only
foster accountability and transparency in drug
regulatory process but would assure the consistency
of information and associated GXP (Good Whatever
Practice) (WHO, Guidance on good data and record
management practices, 2016).
Internationally, the World Health Organization (WHO)
guesses that minimum of 30% of National Medicine
Regulatory Authorities (NMRAs) have partial capacity
to carry out their core regulatory functions. In Africa,
there are 54 NMRAs with different capabilities to
perform regulatory tasks (Ndomondo-Sigonda, Miot,
Naidoo, Dodoo, & Kaale, 2017). Most of these had
fragmented regulatory systems which on several
occasions had been linked to weak legal and
regulatory framework. Gaps and overlaps of
responsibilities were common, especially in licensing
(involving the Ministry of Public Health or Ministry of
Trade) and inspection (involving pharmaceutical
councils, regional authorities, or public health
inspectorates). Organizations of this type have limited
autonomy (WHO, Regulatory Harmonization:, 2010).
An assessment of 26 regulatory systems in sub
Saharan Africa revealed that all of them had critical
weaknesses, including a lack of sustainable funding
and a severe lack of human resources (USAID, 2018).
Most of these NMRAs lack sufficient competent staffs
to realise their mandate. Competency is missing in
core regulatory functions, such as clinical trials
monitoring, inspection of facilities Inspection report
writing, dossier review, bioequivalence data
evaluation,
quality
management
systems
pharmacovigilance and post-marketing surveillance
(Ekeigwe, 2019). In some cases, an unqualified
individual without professional expertise and handson knowledge of regulatory science due to his/her
background or political connection, becomes
employed into an NMRA. Some of these individuals
with minimal regulatory knowledge and experience, in
a short space of time ascend to positions where
sensitive
regulatory
decisions
are
taken.
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Consequently, this creates bottlenecks because their
lack of expertise often results in slow decision making
in situations that should otherwise call for prompt
action in the interest of public health. Also, the
inability of most regulators to get expose to regulatory
sciences and medicine regulation courses during their
early career days in pharmacy schools, science
departments, and other academic institution, explains
their poor performance in execution of their assigned
tasks. Occasionally, these employees may or may not
have the privilege to be trained by their employers. On
the job training becomes the only available option
through which fresh employees struggled their way to
learn (Ekeigwe, 2019).
Strong regulatory systems are required to guarantee
the quality, safety, and efficacy of medical products
and advancement of trade and socioeconomic
development. The strictness in regulation activities
should be guided by the type of the drug formulation,
questions asked during product safety, quality, and
usefulness evaluation, and by complexities of the
pharmaceutical supply chain. All nations then need to
have functional and competent national medicines
regulatory authorities (NMRAs) (Ndomondo-Sigonda,
Miot, Naidoo, Dodoo, & Kaale, 2017) or else make it
would make regulatory processes excessively
complicated, lengthy, and lacking in transparency
(USAID, 2018).
Inspection of manufacturing facilities to assess their
compliance with current good manufacturing practice
(cGMP) regulations is one of the core functions of
National Medicine Regulatory Agency (IAuditor, 2020).
Health risks due to factors like poor hygiene,
inadequate
temperature-control,
crosscontamination, adulteration etc in any step of the
manufacturing process, could lead to fatal
consequences to consumers. As such, Good
Manufacturing Practice (GMP) is implemented by
many manufacturers around the world. It is mandated
by individual countries government to regulate
production,
verification,
and
validation
of
manufactured products to ensure that they are of
good quality, effective and safe for market distribution.
For instance, in the United States of America, GMP is
enforced by the US FDA through Current Good
Manufacturing Practices (CGMP) which covers a
broader range of industries such as cosmetics, food,
medical devices, and prescription drugs (IAuditor,
2020). When a manufacturing site for pharmaceutical
products is assessed, the inspection team that carried
out the audit normally draw up a report which detail
the outcome of observations made during the

exercise. The ability of inspectors to write clearly for a
general audience, as well as the ability to adapt their
mode of writing to different audiences and purposes,
are important competencies they should possess
(Cyn et al, 2014). Success in this area depends much
on the level of the inspector’s proficiency, his
readiness to learn and the open-mindedness to have
the report reviewed to get more constructive
feedbacks on his or her performance. This is not the
case with many regulatory inspectors in West Africa.
Issues on deficiencies in inspection report writing
practice have been areas of great concern which
require attention. These areas of concern include.
Non-uniform application of common standards or
principles (Requirement, Evidence and Deficiency)
that guide GMP inspection report writing. (WHO
2016a). Incomplete capturing of some sections or sub
sections stipulated in the inspection report format of
the NMRA. Non-usage of third person narrative past
tense writing style (WHO 2016a). Listing of observed
deficiencies under a wrong GMP system or subsystem. Inspectional observation(s) not made clear
and specific. Repeat of observations and non-ranking
of the violations in order of significance. Wrong
citation or non-citing of applicable sections of the laws
and regulations administered by the FDA (Gutting,
2013).that validate inspector’s opinion on violation.
Capturing of violations under wrong risk-based
classification status. Non-reporting of GMP systems
or sub-systems “NOT INSPECTED” or VERIFIED.
Conflicting information in the report or subtle addition
of non-existent observation in the report. Evasiveness
in making categorical statement on GMP status of the
auditee (whether it is satisfactory. marginal or
unsatisfactory). Non-endorsement of report by one or
two members of the inspection team. At the end,
timely submission of Inspection report.(WHO 2016a)
Resources and Guidance
Compliance Monitoring

Documents

for

WHO TRS No. 996 2016, Annex 4 provided a
reviewed guidance on good manufacturing practice
for National Medicine Regulatory Authorities. The
document described the common principles and
suggested standardized report format to be used by
regulatory authorities and other establishments that
perform pharmaceutical Inspections. In line with the
provision of this document, writing inspection reports
must produce a accurate and unbiased information on
activities carried out. Inspection rating comments
(both compliant statement and non-compliant
statement) on each GMP system and sub-systems

4

are discussed with the firm’s management during the
close out meetings and conclusion is reached at the
time the report is written(WHO, 2016). The second
reference document on GMP inspection report writing
is WHO Technical Report Series, No. 902, 2002
Annex 8, section 7.4 p 108 on Quality Systems
Requirements for National Good Manufacturing
Practice Inspectorates. This particular document
discussed the need for reports to be signed and dated
by inspectors,(WHO 1992). The third document is
Pharmaceutical
Inspection
Convention
and
Pharmaceutical Inspection Co-operation Scheme
guidance document (PIC/S PI 013-3 1 Annex 25
September 2007) on Standard Operation Procedure
for PIC/S Inspection report format which provided
guidance on the format to be used for preparation of
PIC/S inspection reports(PIC/S 2007). All these
regulatory standards emphasized the need for the
report to be clear, accurate and evidence-based, with
explanation of activities, systems, procedures,
processes, and other observations made during the
audit. Based on this, conclusion can be reached that
GMP inspection report should be such a write up that
can easily assist the target audience, to address
observations made during their facility audit, without
any dispute over observation. (Pharmalex, 2019).

challenge which manifested in the form of nonuniform usage of approved report format, poor
knowledge of technical requirements of GMP,
ineffective use of objective evidence to support
observations, providing evasive answers to inspected
facility GMP status etc., had over time affected the
quality of reports written by their inspectors (WHO,
Guideline on Implementation of Quality Management
System for National Regulatory Authorities, 2019).

Background Information About the Research
Problem

Figure 1.

In one West Africa nation, the National Medicine
Regulatory Agency (NMRA) is the Health Regulatory
Agency
(HRA)
identified
as
overseeing
pharmaceutical products regulation. This is an agency
under the ministry of health established by the
provisions of the food, drug and cosmetic act in subsection xi a and b, section 42 of the country’s 1952
drug law. The primary goal of the organization is to
ensure the safe use of food, medicines and cosmetics
products for beneficial health purposes while
protecting people against harmful effects of
counterfeit and substandard medicines and
unwholesome processed food (Geno & Kim, 2019).
The Inspectorate of the NMRA is an independent arm
that is charged with the responsibility of assessing
pharmaceutical manufacturers compliance with good
manufacturing practice regulations for medicinal
products. Though the department had been
established many years ago, yet the issue of low
expertise in the act of writing GMP inspection report,
was found to be common among her inspectors.
(Please see Figure 1 for more information). The

NMRA Drug
Inspectorate
Ineffective
Report
Writing
NMRA
Inspectors

GMP
Inspection

Tackling Ineffective GMP Inspection report writing in
National Medicine Regulatory Agency
The challenge was earlier blamed on the use of
decentralized procedure which empowered the
regional offices to handle inspection activities under
their territory. Much later, it was found that
subsequent adoption of a centralized approach which
ceded the mantle of co-ordination to the inspectorate
head office, did not reduce the anomalies. No data on
how this deficiency impacted regulatory function of
the organization was provided. As such, the level of
the inspectors’ competence in the act of inspection
report writing and the bottlenecks which it had created
so far were yet to be quantified. Secondly, the
Agency’s policy on sharing reports with auditees was
another area of concern. This is because murky
reporting has factual accuracy problems that can
negatively affect company’s response to inspectional
observations. Thus, leading to re-observation of
poorly captured violations during a re-inspection of
the facility’s corrective actions effectiveness. Thirdly,
the organization’s effort to become one of the
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regulatory partners in regulatory reliance initiative
would suffer a set-back. Reason being that poor
report writing practice, would cast doubt on the
Agency’s capability to assure acceptable level of
GMP
compliance.
Other
setbacks
include,
accumulation of un-cleared drug products’ registration
applications, delay in issuance of marketing
authorization (Ekeigwe, 2019) as revealed in Figure
2 below. Multiple cycles of report review, increase in
process time for report evaluation, increase in
regulatory burden for few proficient inspectors, failure
of the inspectorate to meet the administrative process
timelines. At last, delay in conveyance of observations
to regulated subjects (both local and foreign clients).

_....----......
Inconsistent
Pharmaceutical
Inspection reports
Poor Regulation

Limited Know-how

Ineffective GMP Inspection
Report writing

Hinder Reliance Initiative

Lowly
Rated
Inspectors

Sub-optimal Compliance

Weak
Regulatory
Image

Aim of the Study.
The purpose of the research was to conduct a
retrospective study of a National Medicine Regulatory
Agency (NMRA) inspectors’ competence in the act of
writing GMP inspection report.
Objectives
a. To identify the appropriateness of the reports
through evaluation of their coverage and
practice attributes.
b. To find out the impact of intervention program
on inspectors’ writing performance.
c. To verify the individual reports’ compliance
status with regulatory standards for writing
inspection report.
d. To demonstrate the competence of lead
inspectors in the act of writing GMP
inspection report.
e. To identify the gaps that need to be tackled to
guarantee quality improvement of GMP
inspection reports writing practice among
NMRA drug Inspectors.
Research Questions
The subsequent opinions guided this research.
a. Does the review of NMRA establishment
inspection reports reveal the capabilities of
drug
inspectors
to
effectively
rate
pharmaceutical industries compliance with
cGMP requirements on medicinal products
manufacture?
b. To what extent does a few days GMP training,
by an aid agency impact the writing
effectiveness of GMP inspectors in West
Africa?
c.

Figure 2
Venn diagram characteristics that illustrated the
effects of Ineffective GMP Inspection Report writing.
Based on these findings, the research intended to
identify the proficiency of the study NMRA inspectors
in the act of GMP inspection report writing. The gaps
that exist in the inspectors’ writing practice and make
recommendations on how the deficiencies could be
overcome to meet the desired competence approved
by internationally best practice.

Does
educational
qualification
and
experience of lead inspectors affect their
capability to organize an effective GMP
inspection report?

Need for Pharmaceutical Regulation
Pharmaceutical manufacturing and management are
a complex endeavor. It involves multiple companies
and stakeholders, a myriad of sites, complex multilevel supply chains, and many national and
international requirements and regulations that must
be met to assure the quality of medicines being
produced. This is further complicated by strong
competition within the industry and shifting market
forces, which drive frequent supply and demand
fluctuations (Roth L, et al,, 2017). This litany of
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systems, structures, processes, and practices which
ensure that medicines are consistently produced in
compliance with requirements, specifications,
guidelines or characteristics appropriate to their
intended use and as demanded by the product
parameters are referred to as GMP (WHO, 2007). The
question is what is GMP?
What is GMP?
According to WHO, Good Manufacturing Practices
(GMP) is defined as that part of organizational
resources which guarantees that products are
constantly produced and controlled accordingly. This
implies that there should be strict adherence to
standard requirements, specifications, guidelines, or
characteristics appropriate to the product’s intended
use and as required by the marketing authorization,
clinical trial studies or product specification. The
primary objective of GMP is to manage and reduce
the intrinsic risks in pharmaceutical production to
assure the highest standard of quality, safety, and
efficacy of products and no harm in processes that
involves the making of well-being products (Geyer ,
Varley , & Damaris, 2018).
This implies there should be definite manufacturing
procedures, justified critical production steps, suitable
sites, and warehouse management system. Other
requirements include transport, trained and
competent production and quality control staffs,
adequate quality control laboratory facilities, and
officially approved written procedures and instructions.
Documentary evidence of compliance to all steps in
the approved procedures, effective batch traceability
system, complaints investigation and product recall
system are equally important. Conclusively, the
effective implementation of GMPs not only supports
but equally help to guarantee the safety, efficacy, and
quality of medicines (Roth L, et al,, 2017).
Who is a GMP Inspector?
According to Neil Gunning ham (2012), “being a good
inspector is a job that requires great effort and
determination to carry out his job in the face of
daunting challenges that confront him. GMP
Inspection is an activity which can impact a
company’s viability and may lead to regulatory actions
such as product recalls, loss of sales, placing of
manufacturing lines or entire facilities.

on “HOLD” where gross violations are uncovered and
a negative corporate image for the firm (Woodcock,
2012.). Consequently, an inspector should be an
individual, who is skillful at objectionable condition
identification and assessment; an expert at systems
engineering; competent at regulatory requirements
interpretation; and have good intermediary skill.
Bearing in mind, that manufacturing site inspections
are often a disliked event with regulated entities, the
inspector needs to be firm in execution out his or her
duty.
Role of GMP Inspector
Regulatory compliance assessment of inspected
manufacturing sites against the requirements of
national legislation is identified as the key role of an
inspector. Here, the suitability of a site for the activities
which it sought permit or the one it has already gotten
authorization was evaluated. The inspector was
expected to give technical advice and guidance to
both internal and external customers of the FDA. He
offered support to the implementation and execution
of national regulations in relation to matters that
concern medicinal products (Health Product
Regulatory Authority, 2018).
Competence of GMP Inspector
To assure a universally appropriate and flexible
competency framework which support systematic
strengthening of regulatory professionals. was
developed by WHO. Based on this, the word
“competency” was defined as the knowledge, skills,
attitudes, and behaviors developed through education,
training, and experience (Bruno, Ian, Tina, & Claire,
2019).
Criteria for Rating Competency of GMP Inspectors.
Since verification of the licensee’s compliance with
statutory requirements in the authorization is the main
goal of GMP inspection, the criteria for assessing the
performance of an inspector were listed as follows.
• His or her ability to comprehend the
regulatory
body’s
requirements
for
conducting inspection.
• The inspector’s capacity to consider other
regulatory entities’ remarks during the
inspection process.
• Aptitude to come up with an action plan for
specific facility inspection.
•

Capability to identify safety concerns and
likely deficiencies by observation. Ability to
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make assessment on the safety of a
manufacturing site and its regulatory
compliance status.
• Ability to recognize when immediate actions
were required to rectify non-compliance if
there was imminent likelihood of a safety
significant event.
• His or her ability to guide on how to unravel
the root cause analysis of an objectionable
condition.
• Good understanding of how to use riskbased approach at carrying out an
inspection exercise (IAEA, 2013).
These recommendations were corroborated by WHO
guidance on quality systems requirements for national
good manufacturing practice inspectorates which
proposed specified competency requirement of GMP
inspector which are,
• GMP inspectors should have the requisite
self traits of tact, integrity, courage, and
character to carry out his obligations.
• He or she should be educationally skilled in
a recognized scientific/technological field
that relate to pharmaceutical sciences.
(Relevant knowledge in pharmaceutical
manufacture could be considered an added
advantage).
• Having participated in a cross functional
training course on inspecting GMP systems.
• Possessing sufficient working knowledge of
several regulatory guidelines on GMP for
pharmaceutical products and/or relevant
national regulatory authority GMP inspection
procedures.
• Having undergone appropriate training in the
current procedures and techniques of GMP
inspections before conducting an inspection
(WHO, 2002).

writing where inspectors of an audited facility
compiled facts of inspectional observations in a
simple manner, using standard GMP inspection report
format, followed by conclusions at the end of the

Inspection functions
Core task analysis

GAP ANALYSIS PROCESS
Management
Assessment

~I
'----==------==-- - ~ -7

L

Required
Personnel
KSAs

Existing
Personnel
KSAs

~-

L

Competence Gap
Analysis

-===-~.
K – Knowledge
S – Skill
A – Attitude

Periodic
Review

Competency Measurement Model
The flow chart of competency analysis model in figure
3 summarized the need for management of a
regulatory
authority
to
evaluate
prevailing
competences of their staff, by relating the current with
Ideal competences, execution of gap analysis study
and priority areas selection for necessary action.
GMP Inspection Writing
According to Association of Southeast Asian Nations
(ASEAN) Guideline on GMP for Traditional
Medicine/Health Supplement. the term “GMP
inspection report writing” was defined as that type of

Staff Assessment

Competence filling process
Training, development,
re-organization and recruitment
or out-sourcing

Figure 3
Competence Analysis flow Chart (IAEA, 2013)
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report at the end of the report and signature of the
inspectors (ASEAN, 2017). This agreed with the
provisions of WHO guidance on Inspection reports
which stated the aim of writing an inspection report is
to produce accurate and unbiased information on
activities carried out, findings made whether positive
and negative for each inspected area, as made known
to the company during the close out meetings and a
conclusion that was reached at the time the report
was written.
By this, the above statement supported the fact that.
If it is not documented, then it never happened.
However, in the case of ineffective GMP Inspection
report writing, I would rather state that.
If it was “not documented correctly”, it happened, but
in “deplorable style.
Procedure for NMRA GMP Inspection Report
Writing
Upon completion of an inspection, the report is
prepared by the designated member of the inspection
team using a list of discrepancies written during the
inspection as noted in the NMRA inspector’s
notebook. The team provides in the report facts of
observations (both compliant statement and noncompliant remarks) made during the audit as outlined
in the applicable Inspection report format. The
inspector will ensure that the report captures the
objectionable conditions sighted during the inspection.
The deficiencies are written clearly without ambiguity
and classified as critical, major and others using the
risk-based classification approach described in
Annexure 4 of the study NMRA Inspector’s guide to
GMP Assessment.
The relevant sections of the applicable NMRA GMP
guidelines and regulations where observed violations
are of regulatory significance are cited in the report.
The recommendations of the team are based on the
audit findings on the inspected site with a clear
statement on the status of the auditee’s operations.
The inspection report is compiled, endorsed by the
inspection team, and forwarded to the divisional head
or state manager for review within ten workdays of
completion of the facility audit (NMRA, 2019.).Upon
conclusion that the report complied with standard
practice, it is further processed for issuance of
marketing authorization where the inspected facility
GMP outcome was found satisfactory. Otherwise,
NMRA will provide guidance and timeline for the

regulated entity to develop a plan to effect corrective
actions and revert to the Agency for necessary review
(Bablani & Manthan, 2019).
Characteristics of GMP Inspection Report
The characteristics of an inspection report include
aspects such as the importance and correctness of
the information it contains, the reliability of its
arguments, its legibility, and the relevance of the
matters it covers. Such features are mostly covered in
inspection reporting standards like (WHO, Quality
Systems
Requirements
for
National
Good
Manufacturing Practice Inspectorates, 2002).
Detailed description from another guideline shows
that report template should comprise a title that aid
the reader easily understand its contents. It must
visibly spell out the objective and scope of the
assessment task to establish its purpose and limits.
The inspection processes that were carried out should
be well articulated, the evidence collected, and the
analysis undertaken. The report should also be dated
to provide a timeframe and context to the reader about
the observations made during the exercise. Other
useful "reader aids" to be included in the report are a
list of report rubrics, a keyword index, a glossary (an
alphabetical list explaining terms and abbreviations
used in the report (PASAL, 2020). Once these actions
are accomplished, report’s sharing with concerned
parties should not be a challenge to the inspectorate.
In the instance of this research, the report structure
was categorized into two key features namely the
coverage attribute and the practice attribute of an
inspection report.
Coverage attributes – Those attributes of inspection
report that bordered mainly on the reporting template,
findings made during audit and the objectivity of
evidence that described those findings. The attributes
include.
a. Use of the right inspection report format.
b. Demonstration of good knowledge of report
technical content (Quality Management
System (QMS) and site) or elements of good
manufacturing practice,
c. Provision of objective evidence for
Inspectional observations.
d. Use of third person narrative past tense
(WHO, 2016)
Practice Attributes – Convergence of practices that;
determine the strength of the report, provide
information on the compliance status of the auditee,
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and finally qualify the outcome of the inspection. The
attributes are.
e. Risk-based classification of GMP
deficiencies.
f. Reference of deficiencies to applicable
sections of the guidelines, laws and
regulations administered by the NMRA and
other relevant bodies.
g. Signing off on an inspection report by
members of inspection team.
h. Writing and submission of the report in a
timely manner (Gutting, 2013). (Please
Appendix 2 and 5 for details on assessment
rubrics for GMP inspection report)
Implication of the Study
The study was relevant because, facts and findings
gathered will built on the limited data available on
inspectors’ competence, in the act of writing GMP
inspection report. The research findings on various
inspection teams writing competency would help the
agency address issues of low expertise among her
regulators. Facts obtained from the study could be
used as baseline for future review of inspector’s report
writing abilities within the organization. The study may
serve as a guide to other regulatory authorities (FDA
and non-FDA) on how to assess the capabilities of
their regulators in inspection report writing.
Observations made may be of relevance to study
NMRA regional offices because it would help to instill
uniformity in their report writing abilities. Other
possible gains in the study include reduction in the
number of report review cycles, reduced burden for
experienced lead inspectors, removal of bottlenecks
in administrative functions that relate to issuance of
marketing authorization. Potential barriers murky
reporting will create against study NMRA effort to
partner with other national competent authorities on
reliance initiative would be averted. The investigation
may assist other NRAs to reduce the number of report
queries they received from auditees The goal of
safeguarding public health which ensure that auditees
comply with good manufacturing practice and assure
consumers’ access to quality, safe and efficacious
medicinal products would be achieved (Daniel , 2011).
Definition of Terms and Concepts
Current Good Manufacturing Practices (cGMP),
GMP is also sometimes referred to as "cGMP". The
"c" stands for "current," reminding manufacturers that
they must employ technologies and systems which
are up to date to comply with required quality

approach to manufacturing (ISPE, 2021). As a result,
strict adherence to relevant
requirements,
appropriate to their intended use and as required by
the marketing authorization, clinical trial studies or
product specification is important.(WHO 2007).
Pharmaceutical Inspection: It is an aspect of
universal drug quality assurance system which aimed
at enforcing Good Manufacturing Practice (GMP)
compliance or providing license for the manufacture
of pharmaceutical products. This focuses mainly on
request made by applicants of drug product
registration for marketing authorization (WHO,
Provisional Guidelines on the Inspection of
Pharmaceutical Manufacturers. , 1992).
Inspection report In GMP Context:
is a
documentary evidence used to provide accurate and
unbiased information on activities carried out.
Findings made whether compliant statement or not for
each inspected area. Both of which are made known
to the company during the close out meetings and a
conclusion that was reached at the time the report
was written (WHO, Guidance on Good Manufacturing
Practices: Inspection Report. , 2016).
Report writing in GMP context is the type of writing
where inspectors of an audited facility are writing and
compiling the facts of inspection observations in a
simple manner using standard GMP report format
with their conclusion at the end of the report and
signature of the inspector (ASEAN, 2017).
Inspectors in GMP context is a staff of a National
Regulatory Authority whose principal duty is to
present a comprehensive and accurate information on
standards of production activities, and control steps
relevant for the manufacture of any product. The
inspector advises on ways to improve the in-process
test procedure, or any other regulatory service which
in his or her own view promotes the quality, safety,
and efficacy of pharmaceutical products. (WHO,
Provisional Guidelines on the Inspection of
Pharmaceutical Manufacturers. , 1992).
An inspectional observation: is a finding or remarks
made during an inspection and authenticated by
objective evidence (WHO, Guidance on Good
Manufacturing Practices: Inspection Report. , 2016).
.
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Regulatory System: Regulatory System means a
framework of
legal provisions on Good
Manufacturing
Practices,
inspections,
and
enforcements that safeguard the public health and
provide the authority to assure compliance with its
requirements (Day, 2017)
Competent Inspection team: A team of inspectors
with requisite educational background, auditing
expertise and experience in regulatory mandate that
is
required for successful accomplishment of
assigned inspection duty. (World Health Organization
2019).
Regulatory Convergence and Harmonization was
described as joint activities that was based on
reliance and collaboration by various NMRAs to
develop acceptable documentation that supports to a
large extent common approach to regulatory issues
among themselves. (Ball et al, April 2016)

a. Information on demographic data of lead
inspectors of the twenty-five inspection teams.
a. Educational qualification
b. Field of study
c. Years of cognate experience as
inspectors
b. Quality characteristics of the inspection
reports
Coverage attributes
a. Format
b. Technical content (QMS and Site)
c. Objective
Evidence
for
noncompliance statement
d. Use of third person narrative past
tense.
Practice attributes
a. Risk-based classification of GMP
deficiencies.
b. Reference of deficiencies to right
applicable laws, regulations and
GMP text
c. Signing off on a report by members
of inspection team.

2. METHODS

d

Design and Setting
In undertaking this study, we used purposive
sampling technique to collect (25) paper based GMP
inspection reports which comprised (13) preregistration Inspection reports and ten (12) GMP
reassessment reports for a period of one year and
nine months, starting from March 2017 through
December, 2018 (Conroy, 2010).

Data Collection
Retrospective data were collected from paper -based
inspection reports available on NMRA’s drug
inspectorate database. The activity took place from
8th December 2018 to 15th February 2020 which
depicted a two or more days collection interval for a
single report.
Review of these reports was
accomplished using tools like NMRA drug
Inspectorate inspection format, NMRA drug
Inspectorate SOP for inspection report writing, NMRA
drug Inspectorate guidelines and regulations on GMP
Inspection, the drug inspectors’ handbook, the
national drug inspectorate nominal roll, PIC/S
inspection report format and WHO TRS No. 996 2016,
Annex 4 guidance on GMP inspection report writing.
The data were segregated and analyzed based on the
following variables which are.

c.

Timely submission of inspection
reports

Competence of the inspectors
a. Knowledge competence
b. Skill competence
c. Attitude competence

Data Collation
The collected data was transcribed using the
following steps.
Scoring System for data obtained from Inspection
report.
The scoring pattern or marking guide for observation
made in a particular section of inspected facility,
involved upward and sequential validation of each
rubric. {the components or the sub-components or
criteria} by use of assessment criteria stated in Figure
4. Using this approach, the rubric of interest was
described as “available in the facility” or “not available
in the facility” or “not captured at all in the report”. The
number of rubrics involved in a particular depth of
report evaluation directly reflect the strength of
evidence inspectors used to support observations
they made in a specific GMP system or sub-system.
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Figure 4
Pattern of Assessment and Grading of Inspectional
Observations
The approach used in grading observations made by
inspection teams is listed as follows,
Approach to Scoring Components of Inspection
Report Attributes
The inspection report quality attributes components
(format, technical content, objective evidence and use
of third person narrative past tense) were scored
based on a quality score range of zero (no correct
answer) to maximum score of one (1.) The report
component score was derived from the average sum
up of all the sub-components quality scores that feed
into a particular component of interest.
Approach to Scoring Sub-Components of Inspection
Report Attributes
Here, the score range for a sub-component was also
rated from zero (no correct answer) to maximum.

score of one (1). The sub-component score was
derived from average of sum up of major performance
standards that validate or feed into sub-component of
the report. The criteria used to score a report subcomponent is captured in table 1 and listed as follows,
a. The sub-component that was not captured
in the report and the inspection team is
unaware of major performance standards that
feed into it, will score zero (0). This is because
it showed the inability of the team to identify
the absence of the sub-component of a GMP
system and the team’s failure to report such
uncovered area.
b. The sub-component that was captured in
the report as not available in the facility, but
the team talk about all (not some of) major
performance standards that feed into the
rubrics will score one (1). This is because it
showed the ability of the inspectors to identify
a gap that need to be corrected in the facility’s
GMP system.
c. Sub-component that was captured in the
report as “Not Inspected” and the inspection
team gives acceptable reason in writing for
such action will score = 1. This is because the
inspection team revealed an unresolved
compliance issue, which the team for next
inspection visit need to address during the
exercise.
Caution: Such action would be captured in
the lead inspector’s performance record for
future reference if need be.
d. The sub-component that was captured in
the report as available (only as a subheading in the report without expounding its
status), but the team cannot identify any of
the major performance standards will score
zero (0). This is because the inspectors were
not able to demonstrate knowledge of such
important validation tools.
e. The sub-component that was not captured in
the report as present, but the team identify
all the supporting major performance
standards will scored one (1).
This is
because the Inspection team demonstrated
their capability to identify a gap that need to
be corrected in the facility’s GMP system.
The same principle applies as the depth of evaluation
goes down to assessment of the major performance
standards, minor performance standards and unit
standards as captured in Figure 4.
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Table 1

c.

Method of Scoring Quality Attributes of Inspection
Report
S/N

Status of
Quality
Attributes

1

Not captured in
the report
Captured in the
Report
Captured in the
report as “Not
Inspected”
Capture in the
Report as only
heading or subheading
Not Capture in
the Report

2
3

4

5

Knowledge of
Qualifying
Criteria that
Feed the
Attributes
None

Score

Good

1

Good

1

None

0

Good

1

0

Appropriateness of Inspection Reports
Since there is wide variability in audiences that view
the inspection report, the tone of the report must be
tactful, objective, and constructive. It must be clearly
written with adequate description of all features of an
inspection report. Some readers may want to know
the technical matters as well as the exact regulatory
citations and language. Others may be interested in a
“broader” picture of the inspection to note trends.
Regulatory agencies need to know precise details
regarding violations noted and evidence obtained
during the inspection. To achieve this, a great deal of
appropriateness in the design and construction of the
report is needed to paint complete picture of what
transpired during the inspection task. In that wise, the
research used the steps mentioned below to assess
the extent each report complied to standards of
inspection report writing practice.
a. Identification of all the report quality attributes,
their components, sub-components, and
other report’s rubrics.
b. Risk-based classification of GMP deficiencies
observed during an inspection visit was
captured or not captured in the report.

Development of grading criteria for report
quality attributes, their components, subcomponents, and other assessment rubrics
d. Application of order of importance factor
(OOI) to report components to reflect the
relevance of each component and its impact
on appropriateness of the report.
e. Calculation of each report’s score through
cross-multiplication of average of the sum of
values of components that made up the
coverage attribute with those of the practice
attributes with the use of a risk matrix table.
f. Data generated was classified on the scale
range of {0-3}, {4-6}, {7-9} and {10-12} to
differentiate the reports into categories of;
unacceptable, needs improvement, good,
and excellent reports.
Impact of Intervention Program on Inspectors’
Report Writing Effectiveness
The impact of intervention program was evaluated by
comparing the reports that were written before and
after the intervention program by external GMP
trainers in the study organization. The method
involved selecting two sets of twelve reports that were
written before and after the intervention program
which took place in a period of three days from 7-9
November 2018. A two-dimensional approach that
involved; (a) investigating each team performance on
different report quality attribute and (b) exploring
various teams’ performance on each quality attribute
element was used. Five different numeric scale range
were developed and use to assess program’s effect
on inspection teams’ writing effectiveness as shown
table 2A and 2B. These assessment tools include first
a performance level descriptor that defined inspection
team writing proficiency into four categories (Sender,
2015). The second tool was a four-point Likert scale
that show the numerical change in the number of
report components that occur at four performance
levels of inspection team. The third one is also a fourpoint Likert scale the defined the change in number of
teams at different performance levels during
assessment of a particular quality attribute. The
remaining tools are the impact factor ranking scale
and the impact scale which were used in conjunction
with other tools to generate program impact score on
each inspection team.
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Table 2A
Program Impact Evaluation Tools
Teams’ Performance Level Descriptors
S/N

Performance Level

Scale
Score

1

Very under normal

0-25%

2

Under normal

26-50%

3

Normal

51-75%

4

Above normal

>75%

Change in Number of Team(s)
S/N

Change in Number of Teams
at Various Performance Levels

Scale
Score

1

Insignificant change

1-3

2

Slight change

4-6

3

Significant change

7-9

4

Substantial change

10-12

Change in Number of Report Component(s)
S/N

Change in Number of
Components at Various
Performance Levels

Scale
Score

1

Insignificant change

1-2

2

Slight change

3-4

3

Significant change

5-6

4

Substantial change

7-8

Impact on Various Inspection Teams’ Performance on
each Quality Attribute Element
This pattern of evaluation involved examining how the
various teams performed on a particular
subcomponents/component of an inspection report.
Changes were observed in the number of team(s) at
different performance levels after the program. The
change occurred as either an increase or a decrease
in the number of team(s) at the four levels of
performance used to assess each team’s knowledge
of a particular subcomponents/component. An

increase in the number of teams on any performance
level except very under normal, signifies the program
made positive impact in relation to concerned quality
attribute element under review. A decrease showed
the opposite. No change in number of teams on a
particular performance level signified no impact on
concerned quality attribute element.
Impact on each Inspection Team Performance on
various Report Quality Attribute
This approach involved reviewing the change in
number of quality attribute elements at each
performance level of an inspection team. In this case,
investigation into changes in the number subcomponents of technical content (the seventeen
elements of GMP) at the four performance levels was
carried out first. Then, the results generated from
these changes were used to calculate changes in
number of the report’s components at the four
performance levels. The change in the number of
individual components were used to show how many
components existed at the four performance levels
after the training effort, and each team’s performance
rating on a particular component.
Moreover, a quadrant matrix of components’
performance levels in each team’s inspection report
as column title and change in number of report
components as row title was developed. (Please see
Appendix entitled “Program Impact Analysis Matrix on
Team’s Ability to explain Status of Report
Components”). The impact of the program on each
team’s descriptive ability on report components was
assessed by relating changes in number of report
components (increase or decrease) to components’
performance level(s) in each team’s inspection report.
An increase in the number of components at above
normal level of performance indicate that the
concerned team possess best possible descriptive
potentials over a wider coverage of report
components. But in a situation where they skewed
towards very under-normal level of performance, the
reverse is the case. In any quadrant where change in
number of components overlaps a performance level,
that area defines the nature of impact on inspection
team writing effectiveness. The formular used to
compute the program’s impact on overall
performance of each team is described as follows.
The values of change in number of report component
at four performance levels were multiplied exclusively
with their impact factor values. Then, individually
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divided by the total number of performance levels and
ultimately sum up to give program’s impact score on
each inspection team. The result obtained was
measured on the impact scale to interpret the nature
of impact the program had on the team’s overall
performance. See Appendix 8 for detailed result on
Impact Score Calculation for each Inspection team.
Table 2B
Program Impact Evaluation Tools
Impact Factor Ranking
S/N

Performance Level

Impact
factor

1

Very under normal

1

2

Under normal

2

3

Normal

3

4

Above normal

4

Impact Scale
S/N

Nature of Impact

Scale
Score

1

Strong Impact

7.00-8.00

2

Moderate Impact

5.00-6.00

3

Weak Impact

3.00-4.00

4

No Impact

1.00-2.00

A Comparative Study of Reports’ Compliance with
International Standards and Regulatory Guideline
on GMP Inspection Report Writing
Here, the assessment of each report compliance level
with the requirements of the three regulatory
standards for inspection report writing was carried out.
The basic underlying principle in this analysis focused
on content variation of quality attribute elements in the
three guidance documents. The difference in contents
of report format and the submission timeline in the
three documents served as the main indicator
assessment tool for measuring each report level of

compliance. The varying format sub-components
include introduction, scope of inspection, key
personnel met during inspection, inspection findings
and observations made, and product sample taken
during inspection. For submission timeline of an
inspection report, ten calendar days was set aside by
the study NMRA while the other two r organizations
have theirs as thirty calendar days. The first step of
data analysis process involved the calculation of
compliance percentage of all the quality attributes
elements. This include the compliance percentage of
quality attribute elements that are content wise the
same, and those that are content wise different in the
three guidance documents. A scale score of 0 – 25 as
very low, 26-50 as low, 51-75 for moderate and > 75
for high compliance was subsequently developed.
The grading scale was used to measure the
compliance percentage of each quality attribute
element. (Inclusive of format subcomponents and
submission timelines) with the requirements of the
three standards. The relevance of each report
component and their individual impact on report
appropriateness was calculated by application of
order of importance factor or weight factor (OOI).
Then data gained from the later was multiplied with
the compliance percentage of each report component
to generate compliance score of each inspection
report. Each report compliance score was rated on
compliance Likert scale of {0-2}, {3-5}, {6-8} and {911} and used to determine their compliance levels.
Evaluation of the Lead Inspector’s Competence
Following the general opinion that fresh inspectors
cannot easily assess pharmaceutical GMP, the
research assumed that the performance of an
inspection team strictly lies on the proficiency of the
team lead. This is because there is reasonable belief
that he is experienced in conformity determination. He
is a guidance counsellor on regulatory and
organizational requirements that promote product
quality. He supervises team of regulatory inspectors.
Thus, a failure on his part, would have an
overwhelming effect on the team’s performance
during inspection. In this instance, the research
sought to know the impact of intervention program
conducted by external GMP trainers on the
proficiency of lead inspectors of twelve inspection
teams selected from the study NMRA. The method of
investigation used key three indicators namely,
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Knowledge competence
This was defined as lead inspectors’ knowledge of
accepted report format, technical content (QMS and
site) of the report, the use of objective evidence to
substantiate observations made during inspection
and the use of third person narrative past tense in
their report.
Skill competence
This speaks to lead Inspectors’ ability to assign risk
level to GMP observations Next is their expertise to
cite applicable laws or GMP text that substantiate
observed violations.
Attitude competence
This points at the ability of the team lead to ensure the
report is properly written, endorsed, and submitted
within timeframe as stipulated by the study NMRA
inspector’s guide. The difference in values of lead
inspectors’ knowledge, skill, and attitude competence
before and after intervention program was used to
compute changes in their abilities to write effective
report. A score range of one as maximum value (ideal
value) and any value from 0 – 1 for current values was
used as grading criteria for lead inspector’s
competence. This was further illustrated by use of a
four-point bi-polar Likert scale captured in table 3.
Competence score was computed by adding up the
values of knowledge, skill and attitude competences
and divide it by sum up of all report components’
assigned weights.
Table 3
Scale Score for Inspectors’ Competence
S/N

Likert Scale

Competence level

1

0.00-0.25

Novice or never meet
expectation

2

0.26-0.50

Advanced beginner
or far below
expectation

3
4

0.51-0.75
0.76 – 1.00

Partly competent or
near expectation
Competent or meet
expectation

Gap Analysis of Inspection teams’ Report Writing
Ability
The study involved definition and comparative
analysis of gaps in the inspection team’s ability to
describe observations made during inspection. The
different teams’ performance gaps were assessed
and categorized based on their expertise in reporting
the status of various technical components and
subcomponent of a GMP system. Steps taken to
accomplish the task is listed as follows.
.
• Establishing a benchmark of not less than
75% as minimum score that depicts proficient
performance of an inspection team. This was
derived from cut score of not less than 75%
which stood as proficiency grade in the study
NMRA procedure on writing inspection report.
• Finding the key components of the report
which are technical content, objective
evidence,
risk-based
classification
of
deficiencies, reference of violations to the
right GMP text etc.
• Establishment of the competence gap levels.
• Lastly, identification of gaps displayed by the
various teams in the act of drafting their
inspection reports. (Han van loon, 2004)
(Please see table 4 for detailed information)
The different levels of competence gap exhibited by
inspection teams in the act of writing inspection report
were defined as follows:
Substantial gap: When more than 75% of the total
inspection teams score less than 75% for any
parameter of the report. The gap associated with the
teams’ performance is termed substantial gap.
Significant gap: When between 51% to 75% of
inspection teams, score less than 75% for any quality
attributes of the report. The gap associated with the
teams’ competencies is termed significant gap.
Slight gap: When between 26% to 50% of inspection
teams, score less than 75%. The gap is termed Slight
gap.
Insignificant gap: When between 0% to 25% of the
total number of inspection teams, score less than 75%.
The gap is termed Insignificant gap.
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Table 4

Limitations of the study

Definition of Inspection Teams’ Performance Gap

The initial plan of using sample size of fifty inspection
reports was not possible because of limited number of
the types of inspection reports (pre-registration
inspection report and GMP re-assessment inspection
report) needed for the study. Consequently, the
researcher resolved to use lesser sample size of
twenty-five reports which was the quantity accessible
on the inspectorate data base. The name of the
organization was not disclosed due to its
management policy (Birna et al, 2016). The study was
not restricted to inspection report of a particular drug
formulation report like oral solid dosage, oral liquid
dosage, external preparations etc.
The research did not investigate the effectiveness of
inspection teams’ conclusive statement on audited
facility GMP status. This statement was usually
categorized
as
satisfactory,
marginal,
and
unsatisfactory
with granularity
that provide
information on whether the facility cGMP status is of
high, medium, or low risk rating (TGA, 2016). The
study did not investigate the establishment inspection
reports based on actions taken because of
observations. This implies categorizing the reports
into No Action Required, Needs Improvement and
Official Action Required inspection report. This is
because such practice had not been initiated by the
study NMRA as at the time of this research.

S/N

Performance
rating of each
Inspection team

Number
of
Teams

Performance

1

>75% of total
number of teams
scored < 75% tor
any quality
attribute or subcomponent.

>18

Substantial
gap

2

Between 51% to
75% of total
number of teams
scored < 75% for
any quality
attribute or subcomponent

13-18

Significant
gap

3.

Between 26% to
50% of total
number of the
teams scored <
75% for any
quality attribute or
sub-component

6 -12

Slight gap

4.

Between 0% to
25% of total
number of the
teams scored <
75% for any
quality attribute or
sub-component

0-5

Insignificant
gap

Gap

.
Data Analysis
The collected data were entered and analyzed using
SPSS software program frequency distribution tables.
Chi-square tests were used to test association
between categorized variables. The research used a
sampling technique by which inference was drawn
from values of analyzed sample and generalize to
show proficiency of the Agency’s inspector in the act
of report writing.

3. RESULTS AND DISCUSSION
The research was a retrospective study of twenty-five
GMP inspection reports of a National Medicine
Regulatory Authority somewhere in West Africa
designed to assess the inspectors’ proficiency in the
act of inspection report writing.
Impact of Demographic Characteristics of Lead
Inspectors on their Teams’ Writing Effectiveness
In Appendix 1, the result indicated that of the twentyfive reports used in generation of research datasets,
only one (4.0%) qualified as excellent report. Two
(8.0%) were reported as good reports. Needs
improvement reports and unacceptable reports were
each eleven in number (44.0%). Of eleven (44.0%)
unacceptable reports, seven (63.6%) were written by
inspection teams whose team leads held bachelor’s
degree while the remaining four (36.4%) were drafted
by teams whose lead inspectors possess MSc
degree. The only team that had the lead inspector as
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a PhD holder wrote a good report. None of the good
reports was written by teams whose leaders were
non-pharmacists. Rather, most non-pharmacist lead
inspectors [3 of 4 (75%]] and their teams authored
unacceptable reports. A review of lead inspectors’
years of cognate experience, put the figure at five or
more years. Hence, much expertise was anticipated
in their ability to organize an effective report. But this
was not so as most of the unacceptable reports [8 of
11(72.7%)] were written by teams whose lead
inspectors had more than 15 years cognate
experience. Only [ 1of 10 (10.0%)] lead inspectors
with more than fifteen years of cognate experience
wrote a good report with his team. As the remaining
good report was drafted by a team whose lead
inspectors’ year of cognate experience, did not
exceed ten years. (Please refer to Appendix 1)

Appropriateness of the Reports
a. Excellent Report
Coverage Status
The excellent report [1 of 25(4.0%)] (Report number
12) had a format that meet expectation. Review of the
report show that the inspection team had excellent
knowledge of the technical content. The writers of the
excellent report demonstrated partial mastery in the
use of objective evidence. The team also displayed
good use of third person narrative past tense in their
act of writing inspection report.

good report (50.0%) possess just good knowledge of
it. One of the two teams (50.0%) that wrote good
reports displayed partial mastery in the use of
objective evidence. As the remaining one (50.0%)
showed emerging mastery in its use. One of the two
teams (50.0%) that drafted the good reports
demonstrated good use of third person narrative past
tense while the team that authored the remaining
good report (50.0%) made excellent use of third
person narrative past tense.
Practice Status
The two good reports demonstrated adequate
assignment of risk levels to violations in the range of
51- 75%. In terms of referring observed violations to
the right GMP text, One of the two good reports had
51- 75% of observed deficiencies adequately tied to
the right regulatory text. The remaining good report
had between 26-50% of the violations alluded to the
applicable guidelines or regulations. Under signing off
on an inspection report, one of the good reports was
endorsed by all members of the inspection teams
while the other one was not authorized. Lastly, the
practice component of timely submission of report,
revealed that only one (50.0%) of the two good reports
(Report number 25) was submitted within the
approved timeline.

c. Needs Improvement Reports
Coverage Status

Practice Status
Analysis of the practice aspect of inspection report
writing, shows that the authors of excellent report
correctly assigned risk level to more than 75% of GMP
deficiencies they saw during the inspection visit.
Further review revealed that more than 75% of these
deficiencies were appropriately alluded to the right
GMP text. The excellent report was signed off by all
members of the inspection team. Nevertheless, the
report was not submitted in a timely manner.
b. Good Reports
Coverage status
All the good reports [2 of 25 (8.0%)], (Report number
17 and 25) had format that meet expectation. Findings
in one of the two (50.0%) good reports showed the
authors had excellent knowledge of the technical
content. All the same, the authors of the remaining

Data analysis revealed that all needs improvement
reports [11 of 25(44.0%) inspection reports], (Report
number 7, 8, 9, 15, 16, 18, 19, 21, 22, 23 and 24) had
format that meet expectation. Five of the eleven
(45.5%) teams that wrote the needs improvement
reports had good knowledge of the technical content
as the teams that wrote the other six (54.5%) needs
improvement reports had fair knowledge of the
component. Two of the eleven (18.8%) teams that
authored needs improvement reports demonstrated
partial mastery in the use of objective evidence. Six
of the eleven (54.5%) teams displayed emerging
mastery while the remaining three (27.7%) showed no
mastery in the use of objective evidence. Still on
needs improvement reports, four of the eleven
(36.4%) teams confirmed good use of third person
narrative past tense, 6 of the eleven (54.5%) teams
needs practice even as the remaining one (9.1%)
made no use of it.

18

Practice Status
Eight of the eleven (72.7%) needs improvement
reports, had adequate risk-based classification of
more than 75% of GMP violations observed during
inspection.
Two of the eleven (18.2%) needs
improvement reports had adequately classified
deficiencies in the range of 51-75%. For the remaining
report, the scale range of adequately classified
violations lied between 0-25% of the total number of
deficiencies. Four of the eleven (36.4%) needs
improvement reports had more than 75% of observed
deficiencies adequately referred to the right regulatory
citation, Three out of eleven (27.3%) needs
improvement reports had between 51-75% of their
individual deficiencies properly cited. The remaining
4(36.4%) needs improvement reports had between
26-50% of the observed deficiencies properly
referenced to the right regulatory standard. Eight of
the eleven (72.7%) needs improvement reports were
signed off by all members of the inspection team,
1(9.1%) of needs improvement reports was not
signed off by all members of the team and remaining
2(18.2%) were not signed off at all. Lastly, all but two
of the eleven (18.2%) needs improvement reports
were not submitted in a timely manner.
d. Unacceptable Reports
Coverage Status
Eleven [11 of 25 (44.0%) Inspection reports]
unacceptable reports (Report number 1, 2, 3, 4, 5, 6,
10, 11, 13, 14, and 20) had format that meet
expectation. For other coverage components, only
one of the eleven (9.1%) teams that authored
unacceptable reports demonstrated excellent
knowledge of the technical content. Five of the eleven
(18.2%) teams possessed fair knowledge and poor
knowledge of technical content was associated with
the remaining eight (72.2%) teams that authored
unacceptable reports. One of the eleven (9.1%)
unacceptable reports confirmed that the authors had
partial mastery in the use of objective evidence while
the other ten (90.9%) teams had no mastery in the use
of the component. Out of the eleven teams that wrote
unacceptable reports, two (8.2%) made good use of
third person narrative past tense. One (9.1%) needs
practice, and the remaining eight (72,7%) teams
made no use of it.

Practice Status
Outcome of eleven unacceptable reports revealed
that two (18.2%) had adequate risk-based
classification of more than 75% of observed GMP
violations. One of the eleven (9.1%) unacceptable
reports had correct assignment of risk level to an
observation in the range of 51-75%. Another report
had its own in the range of 26-50%. The remaining
seven (63.6%) unacceptable reports revealed proper
assignment of risk levels in the range of 0-25%. On
issue of citing appropriate regulatory text, one of the
eleven (9.1%) unacceptable reports had between 2650% of observed deficiencies properly alluded to the
right GMP text. Remaining ten (90.9%) unacceptable
reports revealed that 0-25% of the GMP deficiencies
was adequately referenced to right GMP text. Most
unacceptable reports [9 of 11(81.8%)] were signed off
by all the members of inspection team. One (9.1%)
unacceptable report was not signed off by all
members of the team just as the remaining one (9.1%)
was not signed off at all. Four of the eleven (36.4%)
unacceptable reports were submitted in a timely
manner whereas the remaining seven (63.6%) were
not received within the approved timeline. See
Appendix 3 entitled as “Data on Quality
Characteristics of Inspection reports.
Conclusively, among the twenty-five inspection
reports that were selected for the study, one qualified
as an excellent report, two (12%) were categorized as
good reports. Needs Improvement reports were
eleven (44%) in number, and the remaining eleven
(44%) were unacceptable reports. (See Appendix 4
and Figure 5 for study NMRA Inspection Reports’
Classification and their Scores). Team 12 made the
best performance in the act of writing inspection
report in that they scored not less than 75% in four
key components of inspection report. These
components were technical content, third person
narrative past tense, reference to right GMP text and
signing off on a report by members of inspection
team). The same result was recorded in seven of the
seventeen (41%) sub-components of the technical
content. On the contrary, the team’s weak point was
in the practice of late submission of report which has
the risk of causing delay in marketing authorization
issue. Team 12 was followed by team number 25 and
17 which earned the second and the third place with
the data measured during the study.
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Summary on Inspection Teams Performance in
relation to Appropriateness of the Reports
The report authored by team 11 was found to be the
most unacceptable report. This is because it had a
score of less than 25% in fifteen of the seventeen
(88%) technical content sub-components. Also, the
report scored less than 25% in other coverage
attributes except in inspection report format. Lastly,
team 11 report had less than 25% in each of the three
components of report practice attributes except for
signing off on an inspection report by members of
inspection team. This was preceded by team 13 and
5 reports.
Impact of Intervention Program on Inspectors’
Report Writing Effectiveness
Impact on Various Inspection Teams’ Performance on
each Quality Attribute Element
The analysis obtained from assessing impact of
training program on inspectors’ writing proficiency
showed an increase in the number of teams
performing at above normal level of performance. The
increase was clearly observed from the difference in
the values of report components like technical content
{1of 12(8.3%)}, third person narrative past tense {1of
12(8.3%)}, risk-based classification of GMP
deficiencies {3 of 12 (25%)}, Reference of deficiencies
to applicable laws, guidelines etc., {3 of 12(25%)} and
timely submission of report {1 of 12(8.3%) before and

after the intervention program. A decrease in the
number of teams by (16.7%) was noticeable on behalf
of signing off on an inspection report, component.
Besides, no change in number of teams was seen
from the values of format component and the use of
objective evidence component. Program impact on
various teams’ performance at very under normal
level, showed a decrease in number of teams for
values of all report components except format and
timely submission of inspection report. More detailed
description of how the various teams described the
status of inspected facilities was captured in partly in
Figure 6 and fully in Appendix 6, 7 and 8 as follows.
Technical content:
Inspectors’ writing effectiveness of report technical
content showed a significant change in the number of
teams exhibiting very under normal level of
performance. This was evident by the decrease in the
number of teams on this level of performance from a
figure of {8 of 12(66.7%)} before the capacity building
program, to a value of {0 of 12(0.0%)} after the
program. Also, an Insignificant change, and a slight
change were observed in two group of teams
displaying above normal and normal levels of
performance. These changes manifested as an
increase in the number of teams from values of {1of
12 (8.3%)} and {1of 12 (8.3%)} before the program, to
{2 of 12(16.7%)} and {(5 of 12(41.7%) after the
program. Teams exhibiting under normal level of
performance on technical content witnessed an
insignificant increase by {3 of 12(25%)} teams.
Among the seventeen elements of cGMP,
pharmaceutical quality system, material management
system, premises and documentation and procedure
were identified as subcomponents of technical
content, with slight change in the number of teams
performing at above-normal level. Over this, the
change was recognized as an increase from values of
{2(16.7%)}, {2(16.7%)}, {1(8.3%)} and {1(8.3%)}
before the program to {8(66.7%)}, {8(66.7%)},
{5(41.7%)}, and {5(41.7%)} after the training program.
Insignificant changes in the number of teams
exhibiting above-normal level of performance were
noticeable
in
all
other
technical
content
subcomponents
except
for
training,
sanitation/personal hygiene, and good practice in
quality control subcomponents. No change in the
number of teams was witnessed among these
subcomponents. At normal level of performance, the
highest change in the number of teams played out in
good practice in production (prevent contamination)
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Sum changes of Inspectors’ writing performance with respect to the various components of inspection report
before and after the capacity building program
component. Last of all, decrease in number of teams
on above-normal level of performance after the
intervention program was associated with equipment
component.
Objective Evidence
On behalf of this component, there was an
insignificant increase in the number of teams at
normal level of performance from a figure of {2 of
12(16.7%)} prior to the program to a value of {3 of
12(25.0%)} after the exercise. At above-normal level
of performance, no change was observed before and
after the program in the number of teams that used
objective evidence in their report. Lastly, data
available for under normal level of performance
revealed a slight increase from a figure of {1 of

12(8.3%)} before the training activity to {5 of
12(41.7%)} after the exercise.
Third Person Narrative Past tense
An appraisal of this verb tense showed there was a
significant decrease in the number of teams with veryunder normal level of performance in the use of third
person narrative past tense. This change was
confirmed by a shift in value from {8 of 12(66.7%)},
prior to the intervention effort to {1 of 12(8.3%)}, after
the activity. At above normal and normal levels of
performance, an insignificant increase of 1(8.3%) and
2(16.7%) was equally observed in the teams’ use of
the right tense and voice. Lastly, data from under
normal level of performance, showed a slight increase
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of four (34.0%) after the training program.
RiskBased
Deficiencies

Classification

of

GMP

The impact of the intervention program revealed
an insignificant increase in number of teams
properly assigning risk level to GMP violations.
This was notable at above-normal, normal, and
under-normal levels of performance where
increase of not more than three (25.0%) teams
occurred. Finally, a slight decrease was witnessed
in the number of teams at under-normal level of
performance from a value of 6(50.0%) prior to the
training effort to one (8.3%) after the event.
Referring GMP
Regulatory Text

Violations

to

the

Right

On issue of citing applicable laws, regulations and
guidelines that substantiate observations made by
inspectors, the number of teams at normal and
under-normal levels of performance recorded a
slight increase. This was proven by the change in
value from two (16.7%) and zero (0.0%) before the
program to five (41.7%) and 4 (33.3%) after the
exercise. Moreover, improvement in the number of
teams at normal level of performance recorded an
insignificant increase of one (8.3%).
Signing Off on an Inspection Reports
A close look at signing off on an inspection report
indicated a decrease in the number of teams at
above normal and normal levels of performance.
This was confirmed by the change in figures from
nine (75.0%) and one (8.3%) prior to capacity
building event to seven (58.3%) and 0(0.0%) after
the exercise. Besides, no change in the number of
teams performing at under-normal level of
performance occurred. last of all, an increase in
the number of teams at very under normal level
moved from value of one (8.3%) before the
training exercise to three (25%) after the coaching
meeting.
Timely Submission of Inspection Reports
For this report component, there was an
insignificant decrease in the number of teams that
displayed very under normal level of performance.
This downward trend was reflected in reduction
from eight inspection teams (66.7%) in the pre-

training phase to half (six) of the team (50.0%) in
the post-training phase. This caused an increase
at the above-normal level of performance though
it was insignificant change {1(8.3%)} when
compared with changes at other levels of
performance.
Impact on each Inspection Team Performance
In this section, the impact analysis on inspection
team’s writing effectiveness were considered in
two ways which are effect on components of each
inspection report and overall effect on each
inspection team performance.
Effect on each Inspection Team Performance on
Report Quality Attribute Elements
The program impact at four levels of performance
revealed that no substantial increase in the
number of components was recorded at abovenormal level by any of the twelve inspection teams.
The strong impact felt by team four (T4 ) at abovenormal level of performance was occasioned by
significant increase {5 of 8(62.5%)} in the
components they effectively described during their
report writing exercise.. Team twelve (T12)
recorded low impact in their writing abilities due to
a slight-change {3 of 8(37.5%)} they experienced
in the number of components at above-normal
level of performance. Last of all, the program
made no impact at above-normal performance
levels of five teams which are team number three,
five, six, nine and eleven (see Appendix 7 and 8)
Effect on each
Performance

Inspection

Team

Overall

The outcome of program impact evaluation on
each inspection team writing effectiveness was
not an outright success. This is because the
impact felt by each inspection team was less than
optimal. For instance, data on the best impact
{Impact score (IT) = 6.25} the program produced,
was recorded in two inspection teams. According
to this result, it was quite clear that both teams
(team four (T4) and team twelve (T12)) experienced
moderate impact in their writing ability. A weak
impact on report writing effectiveness was evident
in the performance of six other inspection teams
which are; team (T1), (T5), (T6), (T8), (T9 ) and (T10).
Lastly, the training program had no impact on the
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remaining four teams. (Please see Appendix 8 for
more information).
A Comparative Study of Reports’ Compliance
with NMRA Guideline, WHO Model and PIC/S
Requirements on GMP Inspection Report
Writing
Components of inspection report like technical
content, use of objective evidence, third person
narrative past tense, risk-based classification of

observed deficiencies and reference of violations
to the applicable GMP text, which are content wise
the same in the three guidance documents were
not core indicators in the analysis of individual
report’s compliance. The reverse was the case for
some report format subcomponents and
submission timelines which are content wise
different in the three guidance documents. Only
those format sub-components (headings and subheadings) which exhibit content variation in the

Compliance Status of Inspection Reports
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Figure 7

Comparative study of reports compliance level with NMRA guideline, WHO Model and PIC/S Requirement for
Writing cGMP Inspection Report

three guidance documents and submission
timelines, were used to assess each report’s level
of compliance. The five subcomponents and the
submission timeline used in verifying this research
goal are listed as follows.
Compliance Status of Quality Attribute Elements
with the three Reference Standards
Determination of Percentage Compliance of
Report Components that are Content Wise the
Same in the Three Guidance Documents

The percentage compliance demonstrated by
other report quality attribute elements except
format subcomponents and submission timelines,
were the same for the three reference standards.
This is because unlike some format subcomponents and submission timelines which
showed content variation in the three guidance
documents, these quality attributes elements
remain content wise the same in the three
regulatory standards.
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Determination of Percentage Compliance of
Report Components that are Content Wise
Different in the Three Guidance Documents
Only those format subcomponents (headings and
subheadings) which vary content wise across the
three regulatory standards and the submission
timelines were used during the study.
Format Subcomponents
Introduction
Of the twenty-five inspection reports, twenty-three
(91%) showed high level of compliance to
elements of introduction stipulated by study
NMRA guideline on inspection report writing.
Twenty-four (96.0%) reports had similar level of
compliance with PIC/S perspective on what
introductory part of GMP inspection report should.
look like. Moderate level of compliance to WHO
guidance on how to pen down introductory section
were identified in twenty-one (84.0%) reports.
Lastly, low compliance level to NMRA and WHO
standards characterized the introductory section
of report number. 18.
Scope and limitation of Inspection
High level of compliance with WHO requirement
on scope and limitation of inspection was recorded
in the content configuration of the twenty-five
inspection reports captured it. Similar result was
recorded in eighteen (72%) reports level of
compliance with PIC/S position on what scope and
limitation of inspection should contain. Finally,
high level of adherence to NMRA opinion on
should be the content of scope and limitation of
inspection was confirmed in only seven (28%)
inspection reports.
Key personnel met during Inspection.
In two separate instances, twenty-two (88.0%)
reports showed high compliance levels with WHO
and PIC/S requirements on key personnel met
during Inspection. Similar level of compliance is
apparent in the way the subcomponent was
defined in twenty-five (100.0%) reports that
conform to NMRA opinion. Report number 10 had
very low compliance with the requirements of
WHO and PIC/S guidelines on what should be the
content of key personnel met during inspection in
an inspection report.

Inspection team’s findings and Observation
On separate occasions, twenty-one (84.0%)
reports revealed high level of compliance with the
three standards requirements on inspection
team’s findings and observation. The remaining
four (16.0%) reports showed moderate level of
compliance with all the three standards. Lastly, no
report exhibited low compliance level with any of
the reference standard need on Inspection team’s
findings and observation.
Product Sample taken during Inspection Task.
High level of compliance with the three reference
standards of writing is obvious in twelve (48.0%)
reports that comply to NMRA guideline. Similar
result was recorded in thirteen (52.0%) reports
that comply to WHO standard. Finally, thirteen
(52.0%) reports that complied to PIC/S opinion on
product sample taken during inspection showed a
high level of compliance.
Submission timeline
The result analysis showed that fifteen (60%)
reports independently showed high compliance
level for WHO and PIC/S standards, Same
compliance level was seen in only six (40%)
reports’ adherences to NMRA standard. In
summary, the compliance percentage analysis of
report format subcomponents and submission
timelines, unveiled the following results. First,
report number. 8 had the highest number of format
subcomponents {(4 of 5(80.0%)} and submission
timelines three (100.0%) that highly complied to
the requirements of the three regulatory standards.
This was followed by report number 14 and 19
which autonomously have three of the five (60.0%)
format subcomponents and two of the three
(66.6%)} submission timelines revealing high level
of compliance to the reference standards’
requirements. Report number 4 portrayed the
least result with {(1 of 5(20,0%)} format
subcomponent and three separate data on
submission timeline that never complied to the
requirements of the three reference standards.
(Appendix 10. contains detail dataset on report
components that are content wise different).
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Compliance Status of each Inspection Report with
the three Reference Standards
Compliance scale for scoring the different
inspection reports showed that report number 12
displayed high level of compliance with NMRA and
PIC/S requirements on inspection report writing.
Report number 17 had high level of compliance
with only the PIC/S model. None of the report
showed high compliance with WHO requirement.
Moreover, report number 1 and 5 had the lowest
levels of compliance with the requirements of the
three guidelines on inspection report writing.
Lastly, only two reports had all round compliance
with PIC/S requirements. One report had same
with the NMRA standard and none recorded such
with WHO Model (Please refer to figure 7 and
Appendix 9).
Evaluation of Lead Inspectors’ Competence
Proficiency of Lead Inspectors after Intervention
Program.
Knowledge Competence
Analysis showed that all the twelve (100%) lead
inspectors were competent in the use of approved
format.
Two (16.7%) lead inspectors
demonstrated competence in the act of drafting
the technical aspect of the report. Five (41.7%)
were partly competent in constructing technical
section of the report, while the remaining three
(25.0%) never meet expectation (novice). More indepth analysis of the technical content), revealed
that more than five lead inspectors (>41%)
displayed competence in the way they assessed
the companies’ premises, pharmaceutical quality
system (PQS) and material management system.
In this case, eight (66.7%) lead inspectors meet
expectation in their effort to describe the facilities’
pharmaceutical quality system. Another eight
(66.7%) achieved the same level of competence
on material management system. Description of
facility premises was carried out by five (41.7%)
competent lead inspectors. Partial competence on
production & process control and equipment
subcomponents was visible in descriptive abilities
of five (41.7%) lead inspectors. Basic
understanding of sub-components like training
and good practice in quality control were
accomplished by another group of seven (58.3%)

lead inspectors. In the end, ten (83.0%), eight
(66.7%) and six (50%) lead alone never meet
expectation on inspected companies’ sanitation
and hygiene, personnel hygiene, and complaint
management. None of the lead inspectors meet
expectation in their use of the objective evidence
Rather, only three (25%) lead inspectors made
effort to meet expectations (partly competent).
Team No.25 had a team lead with the highest
knowledge competence while the reverse was
noticed with team No. 14 which had a gap value of
0.69. Only one (8.3%) lead inspector ensured a
competent team that wrote their report in third
person narrative past tense. Five (41.7%) lead
inspectors were far below expectation in the use
of the report component. Team 14 lead inspector
was a complete novice in the use of the approved
tense and voice.
Skill Competence
Here,
seven
(58.3%)
lead
inspectors
demonstrated
competence
in
risk-based
classification of GMP deficiencies. On behalf of
citing the right GMP text that substantiate
observed deficiencies, only five (41.7%) lead
inspectors meet expectation for the task. Overall,
report number. 24 showed the least gap in skill
competence with a gap value of 0.36. thereby
making them team with the highest skill
competence. The reverse was recorded with team
14 which displayed great deal of knowledge deficit
(Ayu , 2009)
Attitude Competence
Careful review of this aspect of lead inspectors’
competence disclosed that only team 19 and team
20 never meet expectation on signing off on an
inspection report. Alike, ten (83%) lead inspectors
never meet expectation on requirement for timely
submission of report. In conclusion, the result of
lead inspectors’ assessment showed that after the
intervention program, none of team leads
progressed to the appropriate writing competency
profile (>0.75). Eleven (91.6%) lead inspectors
reached level of partial competence (0.51-0.75).
Another lead inspector went on as advanced
beginner (0,26-0.50). and not one remained a
novice (0.00-0.25) after the training exercise
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Sum changes of Inspectors ’writing competence before and after the capacity building program.
Overall, there were eleven partly competent
inspection teams and one team at advanced
beginner stage after training exercise. (Please
refer to figure 8 and Appendix 11 for specifics).
Competence of Inspection teams’ lead inspectors
Overall, the competence assessment of twentyfive inspection teams in Appendix 12, showed
team 12 leader as the only lead inspector with
appropriate writing competency profile. Fourteen
(56.0%) lead inspectors were partly competent.
Five (20.0%) displayed advanced beginners’ skill.
And the last five (20.0%) were novice team leads
in the act of organizing effective GMP inspection
report.
Performance Gaps in NMRA Inspection Report
Substantial Gap
Generally, there was a substantial gap in the way
majority of the inspection teams described the
technical aspect of facility GMP, the use of
objective evidence to support statement of

observation and the use of right tenses and voice
in their report. This was so because more than
75% of Inspection teams (≥ 19) scored an
equivalent value of 75% or less in an effort to air
their view on quality status of the report technical
content or construct report in required tenses and
voice. (Please see appendix 13 for details).
Results in Figure 9 and Appendix 14 highlighted a
substantial knowledge gap in almost all the teams’
observations on fifteen (88.0%) elements of good
manufacturing
practice.
These
included
sanitation/hygiene, complaint, product recall,
contract production and analysis, self- inspection,
training, personnel hygiene, quality control and
good practice in production with six others.
Sanitation/hygiene and training stood out as the
sub-components (elements of GMP), all the
inspection
teams
{25(100%)}
displayed
appropriate writing competency profile. The same
result was recorded among 23(92.0%) teams in
their use of third person narrative past tense. All
the same, substantial gap was not observed
among the components of skill competence.
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Performance gap demonstrated by the teams in the act of writing inspection report

Significant gap

Slight gap

Significant gap in different teams’ performance
rating was more evident in reports’ components
like technical content, use of objective evidence,
use of third person narrative past tense, reference
of violations to applicable laws and timely
submission of inspection report. For example, in
report components like technical content and use
of objective evidence, two groups of inspection
teams (fifteen (60%) and seventeen (68%) teams)
autonomously displayed significant gap in their
abilities to write on pharmaceutical quality system
and material management system of inspected
facilities. Furthermore, the same significant gap in
assignment of risk levels to GMP deficiencies and
citing of applicable law or GMP text was evident in
writing abilities of two groups of Inspection teams
(fourteen (56%) teams and eighteen (72%) teams).

The gap level labelled slight gap was not recorded
in any team’s descriptive effort on technical aspect
of GMP and use of objective evidence.
Nevertheless, six teams which could not sign off
on their reports were identified.
Insignificant gap
Except for format component, none of the
inspection teams demonstrated insignificant
knowledge gap in their abilities to evaluate the
status of the other seven components of
inspection report. This implies that future training
need should focused first on use of objective
evidence, the right tenses and voice. (Please see
figure 9 for more information)
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4. CONCLUSION
The research was a retrospective study of twenty-five
good manufacturing practice inspection reports (from
March 2017 through December 2018) of National
Medicine Regulatory Authority, Drug Inspectorate,
somewhere in west Africa designed to assess the
inspectors’ capability and competence in the act of
report writing. In the study, the attribute of effective
inspection report writing was found to be lacking
among a good number of regulatory inspectors in a
National Medicine Regulatory Agencies in West Africa.
The frequency of this problem was learned through
review of selected inspection reports to make the
following findings. The appropriateness of the reports,
the impact of intervention program on inspectors’
writing performance, individual reports compliance
status with different models of inspection reports,
inspection
team
leader
inspectors’
writing
competence and gaps that exist in the act of GMP
inspection report writing among the regulatory
inspectors.
In view of the findings made in this study, the
conclusions reached are as follows. The results show
that of the twenty-five inspection teams, one team
(4.0%) wrote an excellent report. Two (8.0%) penned
good reports. Eleven (44.0%) team drafted needs
improvement reports and the remaining eleven
(44.0%) prepared an unacceptable report. Of eleven
(44.0%) unacceptable reports, seven (63.6%) were
written by inspection teams whose team leads held
bachelor’s degree while the remaining four (36.4%)
were drafted by teams whose lead inspectors
possess MSc degree. The only team that had the lead
inspector as a PhD holder wrote a good report. None
of the good reports was written by teams whose
leaders were non-pharmacists. Rather, most nonpharmacist lead inspectors [3 of 4 (75%]] and their
teams authored unacceptable reports. A review of
lead inspectors’ years of cognate experience, put the
figure at five or more years. Hence, much expertise
was anticipated in their ability to organize an effective
report. But this was not so as most of the
unacceptable reports [8 of 11(72.7%)] were written by
teams whose lead inspectors had more than 15 years
cognate experience. Only [ 1of 10 (10.0%)] lead
inspectors with more than fifteen years of cognate
experience wrote a good report with his team. As the

remaining good report was drafted by a team whose
lead inspectors’ year of cognate experience, did not
exceed ten years.
The outcome of program impact evaluation on each
inspection team writing effectiveness was not an
outright success. This is because the impact felt by
each inspection team was less than optimal. For
instance, the best impact {Impact score (IT ) = 6.25}
the program produced was evident in two inspection
teams. More distinctly, the teams (team four (T4 ) and
team twelve (T12 )) individually experienced moderate
impact in their report writing ability. Also, weak impact
on report writing effectiveness was evident in the
performance of six other inspection teams which are;
team one (T1), team five (T5), team six (T6), team eight
(T8), team nine (T9 ) and team ten(T10). Lastly, the
training program had no impact on the remaining four
teams.
In terms of compliance with NMRA guidelines and
model inspection reports (PIC/S and WHO) the study
made this observation. Compliance scale for scoring
the different inspection reports showed that report
number 12 displayed high level of compliance with
NMRA and PIC/S requirements on inspection report
writing. Report number 17 had high level of
compliance with only the PIC/S model. None of the
report showed high compliance to WHO requirement.
Finally, report number 1 and 5 had the lowest levels
of compliance with the requirements of the three
guidelines on inspection report writing.
An assessment of lead-inspectors competence
showed team 12 leader as the only lead inspector with
appropriate writing competency profile. Fourteen
(56.0%) lead inspectors were partly competent. Five
(20.0%) displayed advanced beginners’ skill. And the
last five (20.0%) were novice team leads in the act of
organizing effective GMP inspection report. Finally,
substantial gap was notable among the subcomponents of the reports’ technical contents and
their corresponding objective evidence except for the
pharmaceutical quality system and the material
management system. The same gap was recorded in
almost all {twenty-three (92.0%)} the inspection teams’
efforts to use third person narrative past tense in
report writing. All the same, substantial gap was not
observed among the components of skill and attitude
competence.
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the NMRA should encourage the use of nonpublic regulatory reports to enhance learning
and minimize the gaps that exist in their
inspectors’ writing abilities (Garg, S et al,
2013).

5. RECOMMENDATIONS FOR NEXT
STEPS
The study recommended the following:
.
• Regulatory affairs professionals (NRAs and
regulated entities) and the academia should
collaborate on issue of reviewing pharmacy
and related science school curricula to
capture training on regulatory sciences. This
will assist young graduates that wish to build
their career in Food and Drug Authority
organization or in drug manufacturing site to
acquire basic knowledge on issues that
border on medicine regulation (Gloria et al,
2019)..
• On occasional basis, The NMRA should
expose their fresh inspectors and other
cadres of inspectors to short-course intensive
writing interventions that is jointly delivered by
cGMP expert organizations and regulatory
affairs
writing
specialists.
Content
components of such training program should
focus on higher and lower approach of skillbuilding in effective writing. This includes
developing the main message, arranging
writing in a sensible way, listening to the
pattern and flow of the sentences and
paragraphs, choosing effective vocabulary to
communicate meaning, and introducing the
inspector’s opinion in a way that his audience
will understand him (Miller, Cynthia, An-Lin ,
& Anita , 2015).
• The Management of the NMRA drug
inspectorate should carry out periodic
reassessment of the inspectors’ competence
to improve their performance. This should
include a mentorship program which will
serve as means for closer monitoring and
receiving of daily feedback on the progress of
their performance.
• The study organization should leverage the
opportunity provided by regulatory reliance
pathway. or mutual recognition agreement to
expose their staff to joint inspection programs
where they will share their assessments with
other National Regulatory Authorities’
inspectors, gain from each other’s expertise
and deliberate on any deficiencies in the data
being evaluated (WHO, Good reliance
practices in regulatory decision-making: highlevel principles and recommendations, 2020)
• While ensuring adherence to confidential
agreement with reference regulatory authority,

•

The NMRA should release their staff to
participate in WHO rotational fellowship
which will provide them with a complete set of
the WHO norms and standards that underpin
prequalification. Moreover, opportunity to
review and discuss inspection reports with
high profile inspectors will help participants
improve their inspectorate review process
(WHO, Prequalification: WHO rotational
fellowships: an update, 2016).

•

Reviewers or more experienced inspectors
should ensure that every claim and response
an inspection team gives must be backed up
with objective evidence. This is because
unsupported or poorly explained assertions
will confuse the auditee and cast doubts over
the inspectors’ ability to make accurate
judgement (AIHO, 2017).

•

To ensure precision and fairness, the
inspectors should proofread, edit, and rework where necessary their report before
submission to ensure there is no issue factual
inaccuracy that could result in dispute of
observations (AIHO, 2017).

•

The inspectorate should collaborate with one
or two pharmaceutical manufacturing
industries with unswerving history of
compliance with cGMP on issue of short
course internship programs for their fresh
inspectors. This is because the step will
provide them with practical requirements of
what is expected of them as NMRA
inspectors.
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Appendix 1
Impact of Lead Inspectors’ Demographic Data on their Teams’ Writing Effectiveness

Demographic
Characteristics

Appropriateness of Inspection Reports
Excellently

Good

Frequency

Needs
Improvement

Unacceptable

X2
Chi-

pvalue

square

Educational
level
BSc/HND
MSc
PhD and above

0[0.0]
0[0.0]
0[0.0]

2[12.5]
0[0.0]
1[100.0]

7[43.8]
4[50.0]
0[0.0]

7[43.8]
4[50.0]
0[0.0]

16
8
1`

0

3

11

11

5

Pharmacist

0[0.0]

3[14.3]

10[47.6]

8[38.1]

21

Non-Pharmacist
(Scientist)

0[0.0]

0[0.0]

1[25.0]

3[75.0]

4

1

3

11

11

25

0[0.0]
0[0.0]
0[0.0]

1[14.3]
1[20.0]
1[10.0]

3[68.0]
6[66.6]
2[20.0]

2[28.6]
2[22.2]
7[70.0]

6
9
10

0

3

11

11

25

Total

8.37

0.0770

0.57

0.1723

0.83

0.2656

Qualification

Total
Years of
experience
5-10 years
11-15years
>15years
Total

Note: The values are in numerical form for those before the parenthesis and in percentage for those inside
the parenthesis.
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Appendix 2
Assessment Guide for Evaluating Quality Characteristics of Inspection Reports
Quality
Characteristics
Coverage
Attributes

Components
Format

Sub-components
Sections of the report
•

Technical Content
(QMS and Site)

Use of Objective
evidence to support
inspection rating
comments or
statements of
observation

Seventeen elements of WHO cGMP
•
•

Each element
Assessment criteria

Compliant statement contained.
•

GMP requirements with high
proficiency in command of
evidence

•
•

Use of third person narrative past tense

Risk-based
classification of GMP
deficiencies or noncompliance
statement

Proper assignment of risk level to GMP
violations
Improper assignment of risk level to
GMP violations
Non-assignment of risk level to GMP
violations
Proper citing of applicable regulations
Improper citing of applicable
regulations
Non citing of applicable regulations

Timely submission
of inspection reports

Mastery
Partial mastery,
Emerging mastery
No mastery

GMP requirements for
manufacture of medicines
Deficiency
Compelling evidence of poor
compliance level

Use of third person
narrative past tense

Reference
of
deficiencies
to
applicable
laws,
regulations and GMP
text
(Regulatory
Citation)
Signing off on an
inspection report

Meets expectation.
Near expectation
Not near expectation
Not acceptable
Excellent knowledge
Good knowledge
Fair knowledge
Poor knowledge

Non- compliant statement contained.
•

Practice
Attributes

Sub-section(s)

Grading rubrics

All members of the inspection team.
Some members of the inspection team
Not done by any member of the team
•
•

Timely submission of report
late submission of report

Excellent use
Good use
Needs Practice
No use
More than 75% of violations adequately assigned.
Between 51-75% of violations adequately assigned
Between 26-50% of violations adequately assigned
Between 0- 25% of violations adequately assigned

More than 75% properly cited GMP violations
Between 51-75% properly cited GMP violations
Between 26- 50% properly cited GMP violations
Between 0- 25% properly cited GMP violations

Completely signed off on an inspection report
Partially signed off on an inspection report
No signing off on an inspection report
Timely submitted.
Not timely submitted
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Appendix 3
Data on Quality Characteristics of Inspection reports
Quality
characteristics

Components percentage scale score
{Percentage}

>76

51-75

26-50

Number of teams

Entire team
Components
score

Percentage
Score

0-25

Coverage
Attribute
Format

25

0

0

0

25.00

22.27

89.08

3

7

7

8

25.00

11.00

44.00

0

5

7

13

25.00

7.08

28.32

1

8

7

9

25.00

10.31

41.24

Risk-based
classification of
GMP deficiencies

12

5

1

7

25.00

14.04

57.60

Reference to
relevant GMP
text

7

3

5

10

25.00

10.25

41.00

Signing off on an
inspection report
by Members of
the Inspection
team

19

1

2

3

25.00

20.12

80.84

Submission
timeline

0

0

6

19

25.00

6.00

24.00

Technical
Content
Objective
Evidence
Third person
narrative past
tense
Practice
Attribute
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Appendix 4
NMRA Inspection Reports’ Classification and their Scores
Report
Code No
RC1
RC2
RC3
RC4
RC5
RC6
RC7
RC8
RC9
RC10
RC11
RC12
RC13
RC14
RC15
RC16
RC17
RC18
RC19
RC20
RC21
RC22
RC23
RC24
RC25

Company
Location
L1
L2
L3
L1
L4
L5
L1
L2
L1
L5
L3
L1
L2
L6
L1
L7
L5
L1
L8
L1
L3
L5
L9
L1
L1

Audit Date

181217
22-270317
100818
240817
050218
240718
231018
29-301118
120718
010918
150818
19-200718
23-240118
091118
8-90818.
12-131118
14-151118
22-231118
12-131118
14-151118
10-111218
12-131218
10-111218
18-191218
13-141218

Coverage
Attributes
Score
0.75
1.20
1.98
1.18
0.74
1.25
2.38
1.68
2.21
1.44
1.20
3.00
1.14
1.27
2.06
2.19
2.51
2.09
2.03
2.86
2.67
2.39
2.09
1.64
3.04

Practice
Attributes
Score
1.04
1.22
1.20
1.40
1.04
2.05
2.90
3.12
2.92
2.48
0.80
3.19
0.80
1.20
2.60
2.24
3.19
2.91
2.12
1.27
2.90
2.54
2.56
3.34
2.88

Report
Scores
(CA) X (PA)
0.78
1.46
2.38
1.65
0.77
2.56
6.90
5.24
6.45
3.57
0.96
9.57
0.91
1.52
5.36
4.91
8.01
6.08
4.30
3.63
7.74
6.07
5.35
5.48
8.76

Report grades

Gray
Scale

UR
UR
UR
UR
UR
UR
NIR
NIR
NIR
UR
UR
ER
UR
UR
NIR
NIR
GR
NIR
NIR
UR
NIR
NIR
NIR
NIR
GR

Note: ER – Excellent Report, GR – Good Report, NIR- Needs Improvement Report, UR - Unacceptable Report,
RC No. – Report code numbers and L – Company Location, CA – Coverage attribute and PA – Practice attribute
Scale Score - Excellent Report - (12.00 -15.00), Good Report – (8.00 – 11.00),
Needs Improvement Report -– (4.00 – 7.00), Unacceptable Report – (0.00-3.00)

I
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Appendix 5
Rubrics for Evaluating GMP Inspection Report
Report
Excellent

Good

Needs Improvement

Unacceptable

Shows consistent command of
standard, grade level proficient
to writing requirement. Error
free, as such they do not
disrupt readability and
understanding.

Shows some command of
standard, grade level
above average to writing
requirements. Errors are so
few and so minor that they
slightly disrupt readability
and understandability.

Shows scanty command of standard,
grade level marginal to writing
requirements. Errors are noticeable in
such a way that they significantly
disrupt readability and
understandability in several parts of
the report.

Shows consistent error of standard,
grade level unacceptable to writing
requirements. Errors impede both
readability and understandability

Format
Meet expectation

Near expectation

Not Near expectation

Not Acceptable

Followed approved layout that
should be used for the
preparation of reports

A few errors in the layout
used for the preparation of
reports

So many format errors as to make
report ineffective

Does not follow specified format

Technical Content
Excellent knowledge

Good Knowledge

Fair knowledge

Poor knowledge

Content is thorough, accurate,
explicit, or covered in as much
depth as expected, and is
proficiently described using
relevant performance.
standards in all sections of the
report.

Content is accurate, and is
reasonably described by
using relevant performance
standards in most sections
of the report

Content is partway accurate, and not
as explicit or covered as expected,
and is not adequately described by
use of relevant performance
standards in different sections of the
report

Content is not accurate or complete,
and is not described by use of
relevant performance standards in
most sections of the report

Objective evidence
Mastery

Partial Mastery

Emerging Mastery

No Mastery

Expressed using the specific
GMP terms. Use of relevant
standards of quality. Core
reasoning was drawn from
textual evidence.

Expressed in general GMP
terms. Use of relevant
standards of quality with
slight gaps. Core reasoning
was partially drawn from
textual evidence

Not expressed in the right GMP
terms. Use of irrelevant standards of
quality is applied with significant gaps
or misinterpretation. Core reasoning
was tangential or invalid in relation to
the textual evidence.

Not expressed in GMP terms. No
use of unit quality standards. Core
reasoning showed no idea of
evidence

Use of third person narrative past tense
Excellent use

Good use

Needs Practice

No Use

The right tense and voice were
incorporated in more than 76%
of the report. Ideas display in a
creative way further enhanced
readers’ understanding

The right tense and voice
were applied in about 5175 % of the report and
ideas were comprehensive

The right tense and voice were
incorporated in about 26-50 % of the
report. Also, the ideas were not
comprehensive enough.

Used only present tenses to
communicate. The tense usage
interferes with reader's
understanding,
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Appendix 6
Impact on Teams’ Performance levels on Report Quality Attribute Element (Components).

S/N

Quality
Attribute

Above normal
[ > 76]
Before
After

Normal
[51-75]
Before
After

Under normal
[26-50]
Before
After

Very under normal
[0 – 25]
Before
After

Coverage
Format
12[100]
12[100]
Technical
1[8.3]
2[16.7]
1[8.3]
5[41.7]
2[16.7]
5[41.7]
8[66.7]
0[0.0]
content
3
Objective
0[0.0]
0[.0.0]
2[16.7]
3[25.0]
2[16.7]
5[41.7]
9[75.0]
4[33.3]
Evidence
4
Third person
0[0.0]
1[8.3]
3[25.0]
5[41.7]
1[8.3]
5[41.7]
9[75.0]
1[8.3]
narrative
past tense
Practice
1
Risk-based
4[33.3]
7[58.3]
2[16.7]
3[25.0]
0[0.0]
1[8.3]
6[50.0]
1[8.3]
classification
of GMP
deficiencies
2
Reference to
2[16.7]
5[41.7]
1[8.3]
2[16.9]
1[8.3]
4[33.3]
9[75.0]
1[8.3]
the right
GMP text
3
Signing off
9[75.0]
7[58.3]
1[8.3]
0[0.0]
1[8.3]
1[8.3]
1[8.3]
3[25.0]
on an
inspection
report by
members of
inspection
team
4
Report
4[33.8]
5[41.7]
0[0.0]
0[.0.0]
0[.0.0]
1[8.3]
9[75.0]
6[50.0]
submission
in a timely
manner
Note: The values of the performance parameters (Above normal, normal, under normal and very under normal levels)
are in numerical form for the values before the parenthesis and in percentage for those inside the parenthesis.
1
2
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Appendix 7
Program Impact Analysis Matrix on Team’s Ability to explain Status of Report Components

Components’ Performance Levels in each Team’s Inspection Report
Above
Normal
(> 75%)

Numeral
Change in
Reports’
Components
after
Intervention
Program

Normal
(51-76%)

Under
Normal
(26-50%)

Very Under
Normal
(0-25%)

Substantial
change
(7- 8)
Significant
Change

Strong Impact

Moderate Impact

(5 - 6)
Slight Change
(3--4)
Weak Impact
Insignificant
Change
(1-2)

No Impact
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Appendix 8
Impact Score Calculation for each Inspection team

Before

After

CNC

Impact

Ta

A

N

UN

VUN

Tb

A

N

UN

VUN

Tb -Ta

A

N

UN

VUN

IT

T1a

3

0

0

5

T1b

5

0

2

1

T1b –T1a

2

0

2

4

4.00

Weak

T2a

2

0

0

6

T2b

3

0

1

4

T2b –T2a

1

0

1

2

2.00

Null

T3a

3

0

2

3

T3b

3

1

2

2

T3b –T3a

0

1

0

-1

1.00

Null

T4a

1

1

1

5

T4b

6

1

1

0

T4b –T4a

5

0

0

-5

6.25

Moderate

T5a

3

0

0

5

T5b

3

3

0

2

T5b –T5a

0

3

0

-3

3.00

Weak

T6a

3

1

0

4

T6b

2

0

6

0

T6b –T6a

-1

1

6

-4

3.75

Weak

T7a

3

3

1

1

T7b

2

2

2

2

T7b –T7a

1

1

1

1

2.50

Null

T8a

2

3

1

2

T8b

4

4

0

0

T8b-T8a

2

1

-1

-2

3.75

Weak

T9a

3

0

0

5

T9b

3

2

1

2

T9b-T9b

0

2

1

-3

2.75

Weak

T10a

2

0

0

6

T10b

3

0

4

1

T10b-T10a

1

0

4

-6

4.50

Weak

T11a

5

2

0

1

T11b

4

0

2

2

T11b-T11a

-1

-2

2

1

-1.25

Null

T12a

2

0

0

6

T12b

5

2

1

0

T12b-T12a

3

2

1

-6

6.25

Moderate

IT - Program impact score on
each team writing effectiveness.
TP - Total number of
performance levels
Ta – Team performance status
before program.
Ta – Team performance status
after program.
CNC – Change in number of
report components at four
performance levels of an
inspection team
Impact score formula

A – Above normal level –
>75%
N – Normal level –
Between 51-75%
UN- Under normal level Between 26-50%
VUN – Very under normal level
- Between 0-25%

IT = CCA X VA + CCN X VN + CCUN X VUN + CCVUN X VVUN
TP
TP
TP
TP
Impact scale on team writing effectiveness.
Strong Impact - (7.00 -8.00), Moderate Impact – (5.00 – 6.00),
Weak Impact -– (3.00 – 4.00), Null Impact – (1 00 – 2.00)

VA – Impact factor score at above normal level (4)
VN – Impact factor score at normal level (3)
VUN – Impact factor score at under normal level (2)
VVUN – Impact factor score at very under normal level
(1)
CCA – Change in number of report components at A
CCN -- Change in number of report components at N
CCUN - Change in number of report components at UN
CCVUN - Change in number of report components at
VUN
Note
A Negative CCA, CCN value leads to subtraction during
calculation of IT.
A Negative CCUN and CCVUN does not result in
subtraction of figure when calculating IT.
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Appendix 9
Compliance status of individual reports with NMRA guidelines, and WHO standards and
PIC/S requirements

Inspection
Report
Writing
Standards
Compliance
Scale Score
Inspection
Reports

NMRA
WHO
PIC/S

Compliance Scale Score
High

Moderate

Low

Total
Very low

[9 -11]

[6 – 8]

[3 – 5]

[0 – 2]

1
2

7
6
8

8
10
7

9
9
8

25
25
25
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Appendix 10
Percentage Compliance of Report Components that exhibit Content Variation in the three
Regulatory Standards for Inspection Report Writing
Report
Component

NMRA and
other
Regulatory
Standards

Percentage Compliance [%]

Total

High

Moderate

Low

Very low

[ > 76]

[]

[26-50]

[0-25]

Format Content
Introduction

NMRA
WHO
PIC/S

23[92.0]]
0[0.0]
24[96.0]]

1[4.0]]
21[84.0]
0[0.0

0[0.0]
3[12.0]
1[4.0]

1[4.0]
1[4.0]]
0[0.0]

25
25
25

Scope and
limitation of
inspection

NMRA
WHO
PIC/S

7[28.0]
25[100.0]
18[72.0]

12[48.0]
0[0.0]
0[0.0]

6[24.0]
0[0.0]
7[28.0]

0[0.0]
0[0.0]
0[0.0]

25
25
25

Key
Personnel
met

NMRA
WHO
PIC/S

25[100.0]
22[88.0]
22[88.0]

0[0.0]
1[4.0]
1[4.0]

0[0.0]
1[4.0]
1[4.0]

0[0.0]
1[4.0]
1[4.0]

25
25
25

findings and
Observation

NMRA
WHO
PIC/S

21[84.0]
21[84.0]
21[84.0]

4[16.0]
4[16.0]
4[16.0]

0[0.0]
0[0.0]
0[0.0]

0[0.0]
0[0.0]
0[0.0]

25
25
25

NMRA
WHO
PIC/S
Submission timeline

12[48.0]
13[52.0]
13[52.0]

0[0.0]
0[0.0]
0[0.0]

0[0.0]
0[0.0]
0[0.0]

13[52.0]
12[48.0]
12[48.0]

25
25
25

Sample
taken

Timely
submission

NMRA
6[24.0]
0[0.0]
0[0.0]
21[84.0]
25
WHO
15[60.0]
0[0.0]
0[0.0]
10[40.0]
25
PIC/S
15[60.0]
0[0.0]
0[0.0]
10[40.0]
25
Note: The values are in numerical form for those before the parenthesis and in percentage for
those inside the parenthesis.
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Appendix 11
Competence of Inspection teams’ lead inspectors after intervention program

Team code

Kc

Sc

Ac

Competence
score

Proficiency Level

T1b
T2b
T3b
T4b
T5b
T6b
T7b
T8b
T9b
T10b
T11b
T12b

1.68
1.27
2.19
2.51
2.09
2.03
2.86
2.67
2.39
2.09
1.64
3.04

1.92
0.40
2.24
2.39
2.11
1.86
1.27
1.64
2.54
1.76
2.54
1.68

1.20
0.80
0.00
0.80
0.80
0.26
0.00
1.26
0.00
0.80
0.80
1.20

0.60
0.31
0.55
0.71
0.63
0.52
0.52
0.70
0.62
0.58
0.62
0.74

Partly competent
Advanced beginner
Partly competent
Partly competent
Partly competent
Partly competent
Partly competent
Partly competent
Partly competent
Partly competent
Partly competent
Partly competent

Note: a) Score range = from minimum score (0) to Maximum score (1)
b) Range of competence borders: Novice (0.00-0.25), Advanced beginner (0.26 – 0.50),
Partly Competent (0.51-0.75), Competent (0.76-1.00)
c) Kc = Knowledge competence = Sum up of (Value of F x Weight for F) + (Value of TC x Weight for TC) +
(Value of OE x Weight for OE) + (Value of TP x Weight for TP)
d) Sc = Skill competence= Sum up of (Value of RCD x Weight for RCD) + (Value of RRT x Weight for RRT)
e) Ac = Attitude competence = Sum up of (Value of SO x Weight for SO) + (Value of ST x Weight for ST)
Competence Score = Kc + Sc + Ac /Sum up of (Weight for F + Weight for TC + Weight for OE + Weight for TP +
Weight for RCD + Weight for RRT + Weight for SO + Weight for ST)
Where F = format, TC = Technical content, OE= Use of Objective Evidence, TP = Use of third person narrative past tense
RCD = Risk-based classification of GMP deficiencies, RRT= Reference of deficiencies to right applicable laws,
regulations and GMP text, SO = Signing off on a report by members of inspection team, ST = Timely submission of
inspection report.
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Appendix 12
Competence of Inspection Teams’ Lead Inspectors

Team code

Km

Sm

Mean gap
score.

Competence
score

Proficiency Level

T1
T2
T3
T4
T5
T6
T7
T8
T9
T10
T11
T12
T13
T14
T15
T16
T17
T18
T19
T20
T21
T22
T23
T24
T25

0.75
1.20
1.93
1.18
1.25
1.25
2.38
1.68
2.21
1.44
1.20
3.00
1.14
1.27
2.06
2.19
2.51
2.09
2.03
2.86
2.67
2.39
2.09
1.64
3.04

0.00
0.00
0.00
1.14
0.00
1.25
2.10
1.92
2.39
1.28
0.00
2.39
0.00
0.40
1.80
2.24
2.39
2.11
1.86
1.27
1.64
2.54
1.76
2.54
1.68

1.04
0.80
1.20
0.26
0.64
0.80
0.80
1.20
0.53
1.20
0.80
0.80
1.60
0.80
0.80
0.00
0.80
0.80
0.26
0.00
1.26
0.00
0.80
0.80
1.20

0.22
0.25
0.40
0.32
0.24
0.41
0.66
0.60
0.64
0.49
0.25
0.77
0.24
0.31
0.58
0.55
0.71
0.63
0.52
0.52
0.70
0.62
0.58
0.62
0.74

Novice
Novice
Advanced beginner
Advanced beginner
Novice
Advanced beginner
Partly competent
Partly competent
Partly competent
Advanced beginner
Novice
Competent
Novice
Advanced beginner
Partly competent
Partly competent
Partly competent
Partly competent
Partly competent
Partly competent
Partly competent
Partly competent
Partly competent
Partly competent
Partly competent
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Appendix 13
Gap in Teams’ Ability to Report of Status of Quality Attribute Elements

S/N

Gap level

Benchmark for
gap level
definition

Quality Attribute
Elements

1

Substantial

When more than
75% of Inspection
teams score less
than or equal to 75%

Technical Content

21

84.0

Objective
Evidence
Third Person
Narrative Past
tense
Risk-based
classification of
GMP deficiencies

25

100.0

23

92.0

14

56.0

Reference of GMP
deficiencies to the
right GMP text

18

72.0

Submission of
reports within the
approved timeline

16

64.0

Signing off on a
report by members
of inspection team

6

24.0

Format

5

20.0

gap

Number of teams ≥
19
2

Significant
gap

When between 51
and 75% of all the
inspection teams
score less than or
equal to 75%
Number of teams =
≥ 13 <ꭕ ≤18

3.

4

Slight gap

Insignificant
gap

When between 26
and 50% of all the
Inspection teams
score less than or
equal to 75%
Number of teams =
≥6< x ≤12
When between 0
and 25% of all the
inspection teams
score less than or
equal to 75%
Number of teams =
≥0< x ≤ 5

Number of
teams

Percentage
score
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Appendix 14
Gap in Teams’ Ability to Report Sub-components of Technical Contents
S/N

Gap level

Benchmark
for gap level
definition

Quality
Attribute
component

Sub-components

1

Substantial

When more
than 75% of
the number of
team score
less than less
than or equal
to 75%

Technical
content

gap

Number of
teams ≥ 19

2

Significant
gap

When between
51-75% of the
number of
team score
less than less
than or equal
to 75%
Number of
teams = ≥ 13 x
≤18

Technical
content

Number
of
teams

Percentage
score

Sanitation and hygiene

25

100.0

Personnel

22

88.0

Training

25

100.0

Personnel hygiene

24

96.0

Documentation and procedure

20

80.0

Qualification and validation

20

80.0

Production and process control

23

92.0

Quality control

23

92.0

Premises

19

76.0

Good practice in production

22

88.0

Equipment

21

84.0

Complaint

23

92.0

Product recall

23

92.0

Contract production and analysis

20

80.0

Self-inspection

23

92.0

Pharmaceutical quality system

15

60.0

Material management system

17

68.0

